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Summary 
In this study, the targeted integration of a gene-of-interest (GOI) into pre-characterized loci 
with high and stable expression properties is further elaborated to overcome variable and 
unstable transgene expression caused by position effects that are typical for random 
integration. The Flp-based recombinase-mediated cassette exchange (RMCE) strategy 
permits the exchange of a target cassette for a cassette with the GOI, introduced as part of an 
exchange vector. According to this protocol RMCE enables a ―clean‖ process and it 
overcomes silencing by not co-introducing prokaryotic vector parts nor leaving behind a 
selection marker (―pFAR‖ principle). Contrary to certain single-site recombination strategies 
(such as the ―Flp-in‖ technique) RMCE is a virtually irreversible process that can be driven to 
completion by a molar excess of the exchange cassette and it does not suffer from the 
presence of genomic pseudo-sites as reported for the Cre- and ΦC31-recombinases. 
The present work has extended our RMCE technology and made it applicable for the 
generation of permanent (production-) cell lines that are characterized by an unstable 
genotype due to continuous chromosomal rearrangements. Using a two-step RMCE 
pre-screen, this protocol  
 guarantees the selection of loci with high-level and long-term stable expression of a 
transgene under a given promoter 
 enables a highly efficient ―trap-principle‖ without introducing unwanted 
sequences/elements. This has been achieved via a promoter residing on the target in 
combination with a promoter-free targeting cassette  
 provides persistent exchangeability (i.e. high RMCE potential) 
 promotes the introduction of a single transgene at the target site in the absence of any 
(additional) random integration events 
 selects for sites with properties that are amenable to the transcription-augmenting 
potential of histone deacetylases inhibitors (HDACi). 
The generation of suitable master cell lines is feasible within 8 weeks. These lines permit 
further RMCE cycles within 4 weeks in the absence of any drug selection and with a 
considerable efficiency (~10%). The particular advantages of Flp-RMCE will therefore grant 
its use for Biotechnology, Gene Therapy, Stem Cell/transgenic animal research.  
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1. Introduction 
1.1. Current status in cell line development and engineering 
for recombinant protein production 
1.1.1. Selection of stable cell lines 
During recent years the market for biopharmaceuticals has widely expanded and is expected 
to reach US$ 70 billion by 2010 (Walsh 2006). The bulk of items are recombinant 
protein-based products, which are mostly produced in cultivated mammalian cell lines, among 
which the Chinese hamster ovary (CHO) line is the most prominent one (Trill et al. 1995; de la 
Cruz Edmonds et al. 2006). Traditionally, a transgene under the control of potent transcription 
regulatory elements and a selectable marker gene are randomly integrated into the host 
chromosomes. A stringent selection procedure in media containing a cytotoxic antibiotic or 
devoid of an essential metabolic enzyme is used for the generation of stable transgenic cell 
lines (Wurm 2004). The most common antibiotic resistance marker used is the bacterial 
neomycin phosphotransferase enzyme encoded by the neo gene (Trill et al. 1995; Li et al. 
2007). It confers selectability by the drug G418 in eukaryotic cells. There are a number of 
alternative antibiotic selection markers available (e.g., puromycin, zeocin), but the information 
on their use in mammalian expression systems is poorly reported. The metabolic selection 
markers such as dihydrofolate reductase (DHFR, Trill et al. 1995; Kim et al. 1998) or 
glutamine synthetase (GS, de la Cruz Edmonds et al. 2006) have provided effective platforms 
for high level expression systems. In both cases, cell lines defective in the respective enzyme 
are available. In these systems, selection pressure is applied to the cell culture with an 
inhibitor of the DHFR (methotrexate, MTX) or GS enzymes (methionine sulfoximine, MSX) 
that cause an increase in the number of copies of the selection gene and the transfected 
genes. With these systems, a significant improvement in product yield could reach 5 g/l in 
bioreactor processes (Wurm 2004; Butler 2005). However, since the targeted gene and the 
selection marker gene are transfected and randomly integrated into the host chromosomes, 
the expression level of transfected cells surviving from selection is variable and unstable due 
to different and unpredictable locations of the integrated copies, a phenomenon known as 
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―position effect‖. The co-integrated selection marker might cause repressive effects on 
targeted expression (Artelt et al. 1991) and/or disrupt the expression of neighboring gene 
within a locus (Pham et al. 1996) since the target gene and selection marker gene are mostly 
aligned on a (bicistronic) construct. A further complication arises from the fact that the 
presence of multiple integrated gene copies at different loci tends to cause recombination 
over time accompanied by chromosomal aberration (Derouazi et al. 2006) and/or 
repeat-induced silencing (Garrick et al. 1998) in case of tandem-array integration patterns. 
Furthermore, high-producers only account for a minor portion of successfully transfected cells. 
This fact calls for immediate extensive screening since non- and low-producers tend to 
overgrow the desired producing clones that have to divert their metabolic resources to the 
expression of the gene-of-interest (GOI) (Kromenaker and Srienc 1994). Therefore a 
screening process is necessary to isolate clonal lines stably expressing recombinant products 
at high levels in a timeline-efficient, cost-effective and high-throughput manner.  
1.1.2. Screening of suitable clones for production 
In the existing studies, isolating single clones with desired expression properties usually relies 
on extensive screening of a huge number of individual clones, for which the most commonly 
used method is limited dilution (LD). Although the screening process based on LD and 
subsequent product analysis and characterization is simple and inexpensive, it is laborious 
and time-consuming. After the advent of flow cytometry applied for cell screening, 
subpopulations or single cells can be isolated from the mixture in a short range of time and 
with high throughput. Combined with a cell surface labeling technique using fluorescently 
tagged antibodies that bind to secreted target proteins, high producers can be directly 
evaluated by the fluorescence intensity at the cell surface (Brezinsky et al. 2003). Repeated 
sorting based on the selection of cells with the highest fluorescence intensity results in 
significant increases regarding specific cellular productivity. Kuafman et al. (2008) reported a 
similar method to establish stable cell lines only by repeated sorting steps rather than drug 
selection, which warrants a high degree of homogeneity and stability in gene expression. In 
more refined cell surface labeling strategy, based on semisolid methylcellulose growth 
medium, the high expressers can be visualized as a halo around the colony and even be 
picked up by automated colony pickers (www.genetix.com) according to the halo size. 
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Besides that, many other efforts have been undertaken to improve the screening process but 
the general principle of screening has remained unchanged except that more clones can be 
screened in a shorter time span thereby improving throughput. Progress can only be expected 
if, prior to screening, an enrichment process is applied in order to reduce the number of 
clones needed to be screened and characterized. Finally, even if a transcriptional hotspot is 
hit by incidence, a random screening process cannot guarantee the recurrence of such an 
event.  
For this purpose, reuse of these identified hotspots could dramatically reduce the timeline in 
development of production cell lines for various recombinant proteins. A procedure to this end 
could rely on site-specific recombination, which permits the reuse of loci with the desired 
expression characteristics for the expression of any GOI. Repeated use of the same 
integration site would also simplify the regulatory approvals.   
In brief, an ideal expression system should have the following characteristics. It should: 
1- mediate high and stable expression level in the absence of a drug selection; 
2- co-integrate no auxiliary sequences (selection marker gene, prokaryotic sequences) 
besides the GOI; 
3- accommodate a single copy of the gene in order to reduce variable expression levels and 
genomic instability caused by multiple copies at the same or different integration sites; 
4- enable to repeatedly target a given transcriptionally active site at a reasonable efficiency 
to reduce the number of clones to be screened.  
1.2. Site-specific recombination (SSR) 
In the past decade, a number of site-specific recombinases have been exploited for the 
targeted integration of a transgene into a pre-tagged genomic site, especially for introducing 
mouse mutations in a pre-specified temporal and spatially restricted manner (Branda and 
Dymecki 2004). The combined use of site-specific recombination and gene-targeting or 
-trapping in mouse embryonic stem (ES) cells has provided a useful platform to precisely 
manipulate the mouse genome.  
For applications in mammalian cell culture, this combination matches some, but not all of the 
requirements as stated above. The most widely used site-specific recombinases in 
Introduction 
5 
 
mammalian cell culture are the E. coli P1 phage-derived Cre (Sternberg et al. 1986), the 
Saccharomyces cerevisiae-derived Flp (Buchholz et al. 1996; Schaft et al. 2001) and the 
bacteriophage ΦC31-derived integrase (Thorpe and Smith 1998). These enzymes mediate a 
recombination between two copies of their target sequence, i.e. loxP site (for Cre), 
Flp-recognition target (FRT; for Flp) site or a combination of attP/attB (for ΦC31), respectively, 
which enable to excise (Cre, Flp), insert (Cre, Flp, ΦC31), or invert (Cre, Flp) DNA molecules. 
When two copies of the recognition-target (RT) site are arranged as direct repeats, the 
corresponding enzyme excises the DNA segment intervening the RTs and releases it as 
circular DNA, whereas the reverse reaction leads to an insertion of a circular DNA in case it is 
present at a large molecular excess (Fig 1.1A). Due to thermodynamic reasons, the 
entropy-driven (monomolecular) excision step is much favored over the (bimolecular) 
insertion step (Baer and Bode 2001). When two copies of RT are positioned in inverse 
orientation, the intervening DNA becomes inverted by the action of the appropriate 
recombinase. Thereby, in the presence of recombinase activity, a dynamic equilibrium is 
established, in which half of the products will be in one orientation and half in the other (Fig 
1.1B). In contrast, the ΦC31 integrase, a member of the large family of serine recombinases 
mediates recombination between two different RTs, attP and attB, which leads to the insertion 
of the whole plasmid sequence giving rise to a different product pair of RTs, attL and attR (Fig 
1.1A’). Since the excision would require cofactors (such as excisionase, Xis) that cannot be 
expressed in a biologically active form in mammalian cells, the integration or inversion 
reaction becomes irreversible (Fig 1.1B’), other than for, Cre and Flp (Baer and Bode 2001). 
Although the irreversible integration principle may be favorable, yields are rather low due to 
the fact that an attP site requires negative superhelicity in order to recombine with attB. 
Improvement has been achieved by adding a nuclear localization signal (NLS) to the 
recombinase, whereby its efficiency became comparable to the widely used Cre/loxP system. 
Even through, the conventional ΦC31 system still cannot avoid the integration of prokaryotic 
DNA that is part of the integration plasmid. The consequences of such a co-integration will be 
detailed in the following context.  
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A: Excision/Insertion         B: Inversion 
+
  
A’: Insertion           B’: Inversion 
+
   
Fig 1.1 Products of Flp, Cre and ΦC31 recombination in mammalian systems 
A: Excision reaction of Flp/Cre between two equal-oriented target sites, FRT/loxP, and their 
formal reversal, integration reaction by the addition of a complete vector sequence. B: 
Inversion reaction of Flp/Cre. A’: Insertion reaction of ΦC31 between its RTs, attP and attB, 
leads to new RTs, attL and attR, which cannot be recombined by ΦC31 in the lack of an 
excision cofactor. B’: Inversion reaction of ΦC31 between opposite-oriented attP and attB 
leads to opposite-oriented and irreversible attL and attR sites. 
Due to the insertion function of a recombinase, a plasmid DNA containing the RT-GOI 
construct can be integrated into a genomic site which has been marked with the same RT. 
The recombination is mediated through a single reciprocal crossover between the RTs and 
the whole sequences of the plasmid DNA are integrated. In the persistent presence of 
Flp/Cre-recombinase activity, however, such an event will be immediately reversed in an 
entropy-driven excision reaction. This requires that the rare desired events can only be 
captured by a stringent selection principle (usually based on a positive selection strategy).  
All of the recombinases introduced before have found applications to construct engineered 
CHO cell lines for high-level production of recombinant proteins (Groth et al. 2000; 
Thyagarajan et al. 2001; Kito et al. 2002; Wiberg et al. 2006; Huang et al. 2007). Although, in 
principle, the SSR systems guarantee the reproducible and stable transcription of various 
GOIs at the same genomic site, certain drawbacks still cannot be avoided. For example, a 
FRT/loxP FRT/loxP 
FRT/loxP 
FRT/loxP 
 
Flp/Cre 
Flp/Cre 
FRT/loxP FRT/loxP 
FRT/loxP FRT/loxP 
attP 
attB 
attR attL 
ΦC31 
 
attP attB 
ΦC31 
attL attR 
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selection marker is required in order to enrich the targeted events, which will cause 
un-expected repressive effects as encountered in the conventional cell line development 
processes. Even worse, transcriptional levels of the GOI may be affected by the co-expressed 
selection marker and the negative effect may be fortified by host-defense mechanisms 
against prokaryotic vector parts (Riu et al. 2005). These circumstances should be considered 
when designing novel expression systems. 
1.3. Recombinase-Mediated Cassette Exchange (RMCE)  
An advanced generation of targeted integration strategies relies on Recombinase-Mediated 
Cassette Exchange (RMCE) techniques (Schlake and Bode 1994; Feng et al. 1999; Bode et 
al. 2000b; Baer et al. 2000; Belteki et al. 2003). Since genomic pseudo-sties have been 
reported for Cre and ΦC31, which cause genomic instability and, as a consequence, 
apoptosis (Thyagarajan et al. 2000; Thyagarajan and Calos 2005), we have focused on 
Flp-based RMCE application.  
A wild type FRT site consists of 48 bp, composed of two inverted 13 bp repeats and an 8 bp 
spacer together with a third 13 bp direct repeat and a single additional base pair.  
Figure 1.2: Composition of a wild type FRT site (cf. Table 1 in Schlake and Bode 1994) 
The 8 bp spacer is involved in DNA-DNA pairing during strand exchange. Together with the 
extra repeat, its asymmetry determines the direction of site alignment in the recombination 
event, which will consequently lead to either inversion or excision. Foot-printing techniques 
have defined two 12 bp Flp recombinase binding sites that include 11 bp of each of the 
inverted repeats but only the outermost bases of the spacer, suggesting that most of the 
spacer can be mutagenized without a loss of function. These mutations in the 8 bp spacer 
result in functional FRT variants (Fn), which will recombine with a second site of the same 
composition but not with a wild type one (Schlake and Bode 1994). If sites F and Fn are in a 
strategically favorable position, they can mediate the exchange of expression cassettes in a 
C T T C A A G G A T A A G G C T T C A A G G A T A A G A G A T C T T T C A T A T C C T T G A A G
G A A G T T C C T A T T C C G A A G T T C C T A T T C T C T A G A A A G T A T A G G A A C T T C
spacer
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double reciprocal crossover event, which is called Flp-based recombinase-medicated 
cassette exchange (Flp-RMCE). In this case, Flp-RMCE utilizes a set of two 48 bp FRT sites, 
for instance wild type F and mutant F3 (Schlake and Bode 1994). Under these conditions, 
Flp-RMCE enables the site specific exchange of an expression cassette anchored in the 
genome which is flanked by an F3 site on one end and an F site on the other for an analogous 
cassette which is provided on an ―exchange plasmid‖ (Fig 1.3). 
 
Figure 1.3: Principle of the Flp-RMCE concept. 
First, a +/- selection marker flanked by wild type F and mutant F3 sites is integrated into host 
cell genome as a recombination target. This is done either by random integration or by 
homologous recombination. Only single copy integration cells are recovered by selecting 
against the presence of negative marker or by positive selection or by a combination of both. 
By the action of Flp, exchange between the genomically anchored target cassette and 
exchange cassette is initiated. After this step, non-exchanged parental clones can be 
eliminated by negative selection.  
Compared with the simple site-specific strategy, Flp-based RMCE, combined with a negative 
selection principle (Seibler et al. 1998), enables the ―clean‖ exchange of a selection marker 
for the GOI in the sense that no extra sequences besides the GOI are left behind in the 
genome. These advantages have motivated applications of the RMCE principle for the 
generation of various production cell lines (Feng et al. 1999; Schucht et al. 2006; Kim and Lee 
2008; Malchin et al. 2008), although additional (positive) selection markers had to be 
introduced as a part of the exchange cassette. Since the documented unstable karyotype of 
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CHO cell line lowers the efficiency with which suitable targets can be recovered, major efforts 
have to be undertaken to overcome the main bottleneck, i.e. the identification of 
transcriptional hotspots amenable to the RMCE principle. These hotspots should be 
consistently target-able and mediate high and persistent transcription levels. Ideally, the 
targeted integration events are recovered in the absence of any drug selection to avoid 
cellular stress-related phenomena (Rodolosse et al. 1998), to prevent the repressive and 
disruptive effects caused by the co-expression of a selection marker (Artelt et al. 1991; Pham 
et al. 1996), and to reduce the risk of antibiotic contaminants in industrial fermentation 
processes (Sommerfeld and Strube 2005). 
1.4. Transgene expression in eukaryotic cells 
Recombinant gene expression in mammalian cells is a complicated process with multiple-steps, 
from the activation of transcriptional regulators to the synthesis of a functional protein. It starts 
from transcription, and continues with posttranscriptional processing, translation and 
posttranslational modification. Subsequent steps are protein folding under the control of 
chaperones and final secretion. The level of protein expression is determined by each of these 
individual control points, although, traditionally, transcription is considered to be the dominant 
factor controlling expression rate (Barnes et al. 2003).  
After a transgene has been transfected into a cell and stably integrated into the host genome, 
it is wrapped by histones to form nucleosomes, which are the basic building block of 
chromatin. Both, the genomic locus and the surrounding environment determine its 
expression properties. A transgene inserted into or close to a heterochromatin (highly 
condensed regions of chromatin) is more prone to be silenced than a gene in a euchromatic 
(more open and active) environment. Taking a close look at the molecular level, histone 
modifications including acetylation, methylation, phosphorylation, poly(ADP-ribosyl)ation and 
ubiquitination (collectively known as the ―histone code‖) determine whether a gene is active or 
inactive. Transcriptional repression can occur by histone-deacetylation (Jeppesen et al. 1992) 
and -methylation (Peters et al. 2001; Lorincz et al. 2004) as well as by methylation of the 
transfected DNA’s promoter sequence, whereas an open and active chromatin domain is 
generally associated with histone acetylation (Schlake et al. 1994). Therefore, two 
Introduction 
10 
 
approaches have been adopted to create chromatin environments around the transgene that 
will favor active transcription: the surrounding chromosomal environment is physically 
prevented from depressing transcription or the overall epigenetic environment of the 
surrounding chromosomal DNA is altered by making use of the histone code (Barnes and 
Dickson 2006). These two approaches will be addressed in the following chapters. 
1.5. Introduction of boundary elements 
Eukaryotic genomes are organized into functionally and structurally distinct domains in which gene 
expression is either repressed or facilitated. Individual domains can be maintained independent of 
their surroundings through the establishment of insulators or boundary elements (West et al. 2002). 
Insulator or bordering functions protect genes within a chromatin domain from repressive effects 
arising from the surrounding genomic environment. In order to convey stable and high expression 
levels, incorporating cis-acting DNA elements such as the scaffold/matrix attachment regions 
(S/MARs) and/or genomic insulators into the transgene construct is the usual way to organize an 
artificial mini-domain around the transgene. Recent halo fluorescence in situ hybridization 
(halo-FISH) studies confirm that S/MARs act by organizing eukaryotic chromatin into separate 
loops (Heng et al. 2004). Following histone extraction, these loops can be visualized as part of a 
DNA halo anchored to the densely stained nuclear matrix or chromosomal scaffold (Goetze et al. 
2003). 
S/MARs and their associated sequences have a number of properties, which make them powerful 
tools for designing predictable gene expression systems as parts of integrating transgenes. They 
increase transcriptional initiation rates in the integrated but not in the pre-integrative state. This 
phenomenon has been called ―augmentation‖ as it is different from enhancement. Association of 
loop DNA with the nuclear matrix via S/MAR elements present at the flanks is observed which 
consequently leads to an open access of the transcriptional factors to start the transcription 
machinery (Iarovaia et al. 2005). Moreover, S/MARs can function as insulators to establish a 
physically autonomous domain to block the negative regulatory influences of the surrounding 
heterochromatin (Goetze et al. 2005). When the transgene expression cassette was flanked by 
S/MARs, multi-copy integration with tandem transgene arrays was also observed, which augments 
the transgene expression in a site-independent manner (Klehr et al. 1991; Bode et al. 1996). Last 
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but not least, due to their recombinogenic propensity, S/MARs might also direct the transgene to 
the nuclear matrix and cause integration into regions of the genome with S/MAR-like sequences 
(Bode et al. 2000a). For this purpose, different S/MAR elements were integrated into transgene 
cassette to generate high producer cell lines. The chicken lysozyme 5’ matrix attachment region 
almost fully abolishes the occurrence of CHO cell clones with low transgene expression levels that 
may result from integration into unfavorable chromosomal environments. At the same time it 
increases the overall expression of the transgene, allowing the recovery of producer strains with 
significantly lower screening efforts (Zahn-Zabal et al. 2001; Girod et al. 2005). Using the human β 
S/MAR elements, systems were also developed for expressing high levels of recombinant proteins 
in CHO cells (Kim et al. 2005). 
The 2.2 kb S/MAR element E (http://smartdb.bioinf.med.uni-goettingen.de/cgi-bin/SMARtDB/ 
getSMAR.cgi?SM0000002) used in this study is an EcoRI restriction fragment from the 14 kb 
domain of the human interferon gene, where it is located upstream of the well-characterized 
β-interferon gene (Mielke et al. 1990). The 1.3 kb S/MAR element W 
(http://smartdb.bioinf.med.uni-goettingen.de/) goes back to the first intron of the potato leaf 
stem-specific protein ST-LS1. As element E, S/MAR W has been used to confer 
position-independent expression to a transgene in potato and tobacco plants (Stockhaus et al. 
1987) as well as in mammalian cells. 
Besides S/MARs, there are many other cis-acting DNA elements reported to improve transgene 
expression. Placing the human β-globin locus control region (LCR) in front of a gene construct 
leads to high and stable transgene expression in erythroid tissue of transgenic mice (Grosveld et 
al. 1987). Insulators block the action of the enhancer on the promoter when placed in between. 
Insulators also work as barrier to stop the spread of surrounding heterochromatin. Incorporation of 
the well characterized cHS4 insulator from the chicken β-globin LCR confers long-term stability of 
transgene expression (Pikaart et al. 1998). Integration of ubiquitous chromatin opening elements 
(UCOE) upstream of the transgene also permits rapid expression of a protein in an integration 
independent manner (Benton et al. 2002). Stabilizing anti-repressor (STAR-) elements flanking the 
reporter gene are also able to secure higher levels of stable expression in CHO cells, indicating 
anti-silencing effects (Kwaks et al. 2003).  
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1.6. Synergistic function of S/MARs and HDACi on 
transgene expression 
In addition to the transcription augmentation function introduced in chapter 1.5, S/MARs are 
involved in chromatin remodeling and subsequent transcriptional activation events (Bode et al. 
2000a). When S/MARs are used to flank the transgene cassette, their strand-unwinding 
propensity (Bode et al. 1992) attracts sequence-specific proteins, which in turn fix separated 
strands. The positive and negative superhelicity, both caused by a tracking protein in adjacent 
DNA, can subsequently be released by introducing single strand (ss-) DNA breaks. While 
negative superhelicity (DNA unwinding) enables the immediate transcriptional initiation by the 
transcription machinery (Kay and Bode 1994), positive superhelicity (DNA over-winding) 
would stop the process. Unwinding can be supported by the addition of butyrate to the 
medium as this deacetylase inhibitor induces histone hyperacetylation, which causes 
unconstrained negative supercoils by releasing DNA from the protein core of the nucleosome 
(Bode et al. 1986)  
Histone deacetylase inhibitors (HDACi) such as sodium butyrate (NaBu) were originally 
described for their ability to induce differentiation and cell cycle arrest in cultured cells. HDACi 
could effectively stop the growth of cancer cells at concentrations that cause limited toxicity in 
normal cells since inhibition of HDAC activity affects the expression only 2% of mammalian 
genes (de Ruijter et al. 2003). Consequently, derivatives have been developed to serve as 
anticancer agents in clinical trials for multiple types of cancers. In general, HDACi are capable 
of inhibiting HDACs with varying efficiency [e.g. nano-molar for trichostatin A (TSA) to 
milli-molar for NaBu]. Inhibition of HDACs enables acetyltransferases to hyperacetylate the 
lysine residues located in the N-terminal tails of the four nucleosomal core histones.  
If transgenes are transfected as a part of an S/MAR-flanked artificial chromatin domain, the 
role of core histone hyperacetylation mediated by butyrate becomes obvious: Klehr et al. 
(1992) showed that transcription of the respective transgene was boosted 10-30 fold. 
Therefore HDACis and S/MARs synergize to create and stabilize a topology that is favorable 
for pre-activation of genes (Schlake et al. 1994). 
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1.7. Subject of this study  
As introduced before, conventional transfection and selection strategies for recombinant 
protein production cause unstable and unpredictable expression profiles both due to 
uncontrollable integration sites and the number of integrated copies. Necessary screening 
procedures for suitable production clones are tedious and time-consuming. With the advent of 
site-specific recombination techniques, targeted integration of a transgene into a pre-tagged 
and pre-characterized transcriptional hotspot can be addressed. At the onset of this study a 
selection procedure like the conventional transfection and selection strategy was standard, 
and the co-integration of prokaryotic sequences was considered more or less unavoidable.  
Even though recombinase-mediated cassette exchange (RMCE) strategies had been added 
to the scope of SSR activities, the identification of RMCE-competent transcriptional hotspots 
remained laborious as multiple randomly tagged single clones had to be screened. To 
circumvent this problem, the present study adds one more round of RMCE after tagged and 
targeted clones have been isolated (Fig 1.4). Only successfully re-targeted clones are then 
screened for members, which restore the initial situation at a single site and with a single-copy 
integration of the target. Both, the expression level and the targeting phenomena are 
monitored by the gain or loss of a fluorescent marker. Finally, the correctly targeted clones are 
chosen for the integration of various GOIs, even in the absence of a drug selection marker 
and a chemical agent. The well characterized S/MAR elements E and W are used to flank the 
target and their efficiency regarding transcriptional augmentation in the presence and 
absence of HDACis such as sodium butyrate (NaBu) or valproic acid (VPA) is investigated. 
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Fig 1.4 Schematic view of the novel strategy planned in this study 
CHO-K1 wild type cells are tagged by a set of hetero-specific FRT sites, F and F3. The 
positive/negative (+/-) selection marker residing between the F and F3 sites is used to select 
the tagged cells. In the first round of RMCE (RMCE 1), a fluorescent reporter on an analogous 
exchange cassette replaces the +/- marker. The exchanged cells are enriched by negative 
selection and sorted for high expressers. In RMCE 2, the +/- marker is used once more to 
replace the fluorescent marker via a positive selection, which leads to restoration of the initial 
situation (non-fluorescence and resistant to positive selection). To this end, single clones are 
screened for presence of a unique targetable site. S/MAR elements E and W are used to flank 
the +/- selection cassette at the beginning. 
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2. Results  
2.1. Aims of this study 
Recombinase-Mediated Cassette Exchange (RMCE) techniques enable the targeted 
integration of a gene-of-interest (GOI) into a pre-defined genomic locus with desired 
expression properties. The application of RMCE for cell line developments aimed at 
biotechnological applications is of obvious advantage for the following reasons: 
 the predictable expression of a GOI into a pre-characterized integration locus 
reduces the variability caused by position effect variegation (PEV)  
 the re-use of a defined integration site ensures the homogeneity of cell growth 
properties  
 the re-use of the same integration site will also reduce downstream processing 
workloads and simplify regulatory approvals.  
So far, the bottleneck of RMCE for these purposes lies in the isolation of integration sites with 
both, the desired expression properties and a consistent exchangeability. In conventional 
RMCE, the identification of targetable sites relies on extensive screening procedures aimed at 
individual clones, which, though laborious and time-consuming, does not grant the ultimate 
success. Therefore the major topic of this study is the development of a new method to 
efficiently generate clones that bear single copy integration of a targetable genomic site with 
both a high expression level and a consistent exchangeability. Clones with these properties 
can form the basis of potential master cell lines. They will be further tested for their 
exchangeabilities in the absence of any drug selection. Our final goal is a production cell line 
for various GOIs, derived by a ―clean‖ RMCE procedure (no drug selection, no auxiliary 
sequences besides the GOI) within a short period of time.   
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2.2. Strategy I 
2.2.1. Overview of Strategy I 
For conventional RMCE, drug selection has been the only way to enrich for authentic RMCE 
events. In our strategy, we introduce one additional round of RMCE to select for readily 
exchangeable targets. RMCE therefore is used both to distinguish exchangeable from 
non-exchangeable sites and to integrate the GOI into a suitable genomic target site with 
predictable expression properties  
These two rounds of consecutive RMCE steps are outlined in Fig 2.1. In this study, we define 
as a ―cassette‖ a segment of DNA that is flanked by a set of Flp-Recognition Target (FRT) 
sites. This set consists of an FRT-mutant, ―F3‖ (spacer sequence TTCAAATA) and an 
FRTwt-site ―F‖ (containing the unchanged spacer sequence TCTAGAAA; Schlake and Bode 
1994).  
As a first step a so-called ―parental cassette‖, containing a hygromycin (hyg) thymidine kinase 
(tk) fusion gene (hygtk) under control of the HSV-thymidine kinase promoter (Ptk), is randomly 
integrated into CHO-K1 wild type (wt) cells to generate a Hygromycin (Hyg-) resistant strain 
by selection. This parental cassette can be supplemented, with advantage, by scaffold/matrix 
attachment regions (S/MARs): Being bordering elements S/MARs have been found to effect 
transcriptional augmentation by shielding against repressive actions at the integration loci 
(Bode et al. 2003; Abranches et al. 2005). Moreover, due to their strand-separation propensity 
(Bode et al. 1992), S/MARs were also found to increase the exchange potential (Qiao 2005). 
Therefore, in the parental cassette, the 2.2 kb human S/MAR element E (S/MAR-E) and the 
unrelated 1.3 kb plant S/MAR element W (S/MAR-W) are used as flanks, respectively (Goetze 
et al. 2005). A corresponding, non-S/MAR-flanked, parental cassette is used for comparison. 
The choice of two vastly different S/MARs is dictated to avoid genome instability that might 
arise from recombination between identical sequences. 
In the first exchange reaction (RMCE 1) the parental cassette is replaced by another cassette 
with the same set of FRT sites (F3 and F, respectively), carried by an ―exchange vector‖. This 
exchange vector contains, as a fluorescent marker, the d2egfp gene [a destabilized variant of 
enhanced green fluorescent protein (egfp) with a half-life of approximately two hours], driven 
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by a cytomegalovirus promoter (Pcmv). According to the RMCE principle, exchange of the 
hygtk by the d2egfp cassette generates fluorescence, which serves as a traceable marker to 
evaluate the transcription level of targeted cells by FACS analysis (Kalejta et al. 1999). 
Selection is done by Ganciclovir (Ganc), which is a pro-drug excluding non-exchanged 
parental cells due to the viral suicide tk gene encoding the Thymidine Kinase (TK) from HSV 
[so called ―negative-selection‖ principle (Seibler et al. 1998)]: upon the expression of the tk 
gene, Ganciclovir is converted into a phosphorylated nucleotide analog, which, after 
incorporation into the DNA of replicating eukaryotic cells, causes their death (Tomicic et al. 
2001). For the population surviving Ganc selection, cells with high d2egfp expression can be 
collected by FACS. To this end, the expression of d2eGFP is ideally due to the 
RMCE-mediated integration of the exchange cassette. Unfortunately, the random integration 
of the exchange cassette into cells that acquired a spontaneous Ganc resistance due to either 
mutation or deletion (or a combination of these two situations) will also lead to fluorescent 
survivors (Seibler et al. 1998). In order to isolate those cells that owe their fluorescence 
exclusively to the desired RMCE-mediated integration, a second RMCE-step (RMCE 2) has 
been devised in order to restore the initial situation (non-fluorescence). This is done by 
replacing the d2egfp gene by an exchange cassette encoding a hygtk fusion gene, driven by 
the phosphoglycerate kinase promoter (Ppgk). Such an event causes the targeted cells to lose 
fluorescence again. Among the non-fluorescent population, clonal cells are screened and 
characterized by PCR and Southern blot analysis to identify those that in fact underwent two 
rounds of authentic RMCE. Clones with single copy integration at the unique target site can 
then be isolated to establish a master cell clone enabling the development of production cell 
lines for various GOIs. This process can again be supported by a Ganc counter-selection to 
enrich the authentic exchange events. 
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Figure 2.1: Overview of Strategy I 
A ―cassette‖ is defined as a segment of DNA that is flanked by a set of FRT sites - in this study 
the wild type FRT and the mutant FRT3 site. S/MAR elements E and W are used to flank the 
parental cassette to shield the target from heterochromatization and to increase RMCE 
potential. A parental cassette without S/MAR flanks is used for comparison.  
The parental cassette containing the Ptk-driven hygtk fusion is electroporated into CHO-K1 wt 
cells to generate a Hyg-resistant strain. Following selection, a cassette with the fluorescent 
marker d2egfp is used to replace the hygtk cassette via RMCE 1. Formally this means the 
―clean‖ exchange of two expression units without the co-introduction of unwanted vector 
sequences.  
Cells with high expression levels can be enriched by FACS and are expected to contain a 
major RMCE-generated sub-population. Subsequently, in RMCE 2 the initial situation is 
restored by replacing the d2egfp gene with a hygtk fusion – in this case driven by the pgk 
promoter (Ppgk). Cells undergoing authentic RMCE are expected to have lost fluorescence 
after RMCE 2 and can be screened and characterized accordingly. Finally, the clones with a 
consistent exchangeability and a single copy integration of the target are chosen to develop 
production cell lines for various GOIs.   
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2.2.2. Establishment of parental cells in Strategy I 
The plasmids F3-hygtk-F and EF3-hygtk-FW (Fig. 2.2) were linearized by ScaI or by AscI for 
non-S/MAR- and S/MAR-flanked parental cassettes, respectively. After gel-purification, 3 μg 
linearized DNA of each was electroporated into 1E5 CHO-K1 wt cells. Following 
electroporation, an appropriate number of cells were seeded into T75 flask with media 
containing 650 U/ml Hygromycin. After colonies had appeared 7~10 days later, cells were 
pooled and passaged under Hygromycin selection until the transfection for the first round of 
RMCE. Continuous Hyg-selection anticipates the expression of an intact hygtk fusion gene 
and reduces spontaneous resistance phenomena (Seibler et al. 1998). The non-S/MAR- and 
S/MAR-flanked cell mixtures were named “C1” and “C2” respectively, throughout the following 
experiments. 
AscI AscI
ScaI ScaI
 
Figure 2.2: Schematic representation of the parental cassettes integrated into CHO-K1 
wt cells by electroporation 
The ScaI- or AscI-restricted parental plasmids F3-hygtk-F and EF3-hygtk-FW was 
electroporated into CHO-K1 wt cells, respectively, to generate Hygromycin-resistant cell 
mixtures, designated as either “C1” (non-S/MAR-) or “C2” (S/MAR-flanked parental cells). 
2.2.3. First round of RMCE in Strategy I 
The first round of RMCE (RMCE 1) on “C1” (left) and “C2” (right) cells is presented in Fig 2.3A. 
3 μg exchange plasmid F3-cmvd2egfp-F with an exchange cassette expressing d2egfp and 1 
μg pFlpe (―enhanced Flp‖ according to Buchholz et al. 1998) were co-transfected into “C1” 
and “C2” cells respectively (Fig. 2.3A). One day post-transfection, 2.5 μg/ml of Puromycin was 
added to the culture medium to enforce the expression of Flpe based on the obligatory 
co-expression of the puromycin resistance gene that is co-expressed from the 
flpe-IRES-puromycin (flpe-pac) cassette (Taniguchi et al. 1998). Two days post-transfection, 
C1 
C2 
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20~30% of the highest d2eGFP expressing population was collected by FACS (Fig 2.3B). 
Since the S/MAR elements do not augment gene expression in the transient phase, no 
difference of the transfection efficiency between “C1” and “C2” was observed (Bode et al. 
2000a). The sorted cells were named “10/06-C1” and “10/06-C2” for non-S/MAR- and 
S/MAR-flanked constructs, respectively. Following this step, 10 µg/ml Ganciclovir (Ganc) was 
added to the culture medium to exclude non-exchanged “C1” and “C2” cells. After 10~14 days, 
colonies had developed. After “10/06-C1” and “10/06-C2” cells had grown to confluence, the 
expression pattern of each population was determined by FACS analysis (Fig 2.3C). The fact 
that cells in “10/06-C2” expressed more d2eGFP than those in “10/06-C1” can, in principle, be 
due to several reasons: 
1. S/MARs flanking the targeted cassette can alleviate silencing effects from the gene 
environment and thereby retain expression properties;  
2. S/MARs can increase transfection efficiencies, i.e. the number of integrated 
transgene-copies, possibly due to their effect on single-strand DNA (ssDNA-) end 
formation (Klehr et al. 1991); 
3. Due to their strand-separation potential, S/MARs have the potential to increase the rate of 
RMCE, which leads to a higher contribution of exchanged cells within the survivors.  
Since only the cells with high expression level were of interest, the second sorting by FACS 
(Fig. 2.3C) was performed to collect the highest eGFP expressing cells from both “10/06-C1” 
(1%) and “10/06-C2” (10%), which were termed “10/06-C1-S” and “10/06-C2-S” (Fig 2.3D) 
accordingly. In order to verify the components of cell mixtures, several PCRs were performed 
on the genomic DNA both for “10/06-C1-S” and “10/06-C2-S”.  
The first PCR was performed to trace the authentic exchange events within the high 
expressers that had been enriched by double sorting. Primer pairs were designed such that 
the forward (5’-) one was positioned upstream from the F3 site for the parental plasmid and 
the backward (3’-) one was placed within the exchanged cassette (F3-cmvd2egfp-F), as 
indicated (p2494/pGFP6 for “10/06-C1-S” and p2495/pGFP6 for “10/06-C2-S”) in Fig. 2.3A. 
Upon targeted integration by RMCE the amplified segment will be unique. PCRs on genomic 
DNA of CHO-K1 wt cells and on parental cells “C1” and “C2” were performed as negative 
controls. Authentic exchange events gave rise to a ~1.0 kb band and a ~900 bp band for 
non-S/MAR- and S/MAR-flanked cells respectively, as indicated in Fig 2.3E. 
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p2494 pGFP6
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p2495 pGFP6
900 bp
p2494 p2471
520 bp
p1452 p2471
1.1 kb
p1230 p2484
900 bp
p1230 p2484
900 bp
 
            
               
                
          
Figure 2.3: First round of RMCE in Strategy I 
A: An exchange plasmid containing a cassette (flanked by F3 and F sites) with the d2egfp gene 
under control of the cmv promoter (Pcmv) was co-transfected along with pFlpe into “C1” and “C2” cells 
(see Fig 2.2). Flpe is encoded as part of a bicistronic flpe-IRES-puromycin (flpe-pac) cassette. B: At 
the transient stage, 20~30% of highly expressing cells were sorted by FACS and then subjected to 
Ganc selection. C: Ganc-resistant cells were sorted once more to obtain the highest expressing cells 
(1% for non-S/MAR- flanked cells; 10% for S/MAR-flanked cells). D: Double-sorted cells showed 
stable fluorescent expression. E: PCR was performed to verify authentic exchange events in the 
florescent cells shown in ―D‖. The primer pairs used for PCR verification are indicated on the 
exchanged cassettes in ―A‖. PCRs on H2O and genomic DNA of CHO-K1 wt, “C1” or “C2” were 
performed as negative controls (-). M: 1.0 kb marker. 
10/06-C1 
10/06-C1-S 
10/06-C2 
10/06-C2-S 
B 
C 
D 
1. H2O (-) 
2. CHO-K1 wt (-) 
3. C1 (-) 
4. 10/06-C1-S 
1. H2O (-) 
2. CHO-K1 (-)wt 
3. C2 (-) 
4. 10/06-C2-S 
E 
A 
1.0 kb 900 bp 
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The second PCR was performed to detect whether the silencing of the tk gene in the parental 
cassette led to the survival of non-exchanged cells among “10/06-C1-S” or “10/06-C2-S”. 
Therefore a primer pair was designed such that the forward one (5’-) was placed upstream 
from the F3 site for the parental plasmid while the backward one (3’-) was introduced into the 
parental cassette, F3-hygtk-F (p2494/p2471 for non-S/MAR-flanked cells and p1452/p2471 
for S/MAR-flanked cells, see Fig 2.3A). PCRs on the genomic DNA of “C1” and “C2” were 
performed as positive controls. A band of ~520 bp and of ~1.1 kb for “10/06-C1-S” and 
“10/06-C2-S” respectively were found not only in the parental cells (positive controls) but also 
in the cell mixture after RMCE 1 (Fig 2.4), which indicated the silencing of the tk gene caused 
the Ganc-resistance of at least some parental cells after RMCE 1. In addition, the loss or 
mutation of the tk gene may have led to spontaneous Ganc-resistance as well. 
 
 
 
 
 
 
Figure 2.4: PCR analyses trace silenced tk genes for “10/06-C1-S” and “10/06-C2-S” 
cells 
PCR reactions on genomic DNA of “10/06-C1-S” and “10/06-C2-S” cells were performed with 
the primer pair indicated in Fig 2.3A. The same PCRs were performed with genomic DNA of 
“C1” and “C2” (Fig 2.2) as positive controls (+) for non-S/MAR- and S/MAR-flanked cells 
respectively. PCR reactions on H2O and genomic DNA of CHO-K1 cells were used as 
negative controls (-). The PCR signals indicate the existence of silenced tk genes in 
Ganc-resistant “10/06-C1-S” and “10/06-C2-S” cells. M: 1.0 kb marker. 
The third PCR was performed to detect whether random integration(s) of the exchange 
plasmid also contributed to the GFP expression of “10/06-C1-S” and “10/06-C2-S” cells. The 
primer pair p1230/p2484 is indicated on the exchange vector F3-cmvd2egfp-F (Fig. 2.3A), 
which led to a 900 bp amplified fragment as a positive control. PCR analyses were performed 
on the genomic DNA of “10/06-C1-S” and “10/06-C2-S”. As shown in Fig 2.5, a randomly 
integrated F3-cmvd2egfp-F construct was detected for both “10/06-C1-S” and “10/06-C2-S” 
M  1   2   3   4   5   6   7   8   M
 
1.1 kb 
1. H2O (-) 
2. CHO-K1 (-) 
3. C1 (+) 
4. 10/06-C1-S 
 
5. H2O (-) 
6. CHO-K1 (-) 
7. C2 (+) 
8. 10/06-C2-S 
520 bp 
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cells but not in parental cells “C1” and “C2” that served as negative controls.  
 
 
 
 
 
Figure 2.5: PCR analyses to visualize random integration(s) of the exchange plasmid in 
RMCE 1 
PCR was performed as indicated in figure 2.3A on the exchange vector F3-cmvd2egfp-F. A 
900 bp PCR band with genomic DNA of “10/06-C1-S” and “10/06-C2-S” showed that there 
were random integration(s) of the exchange plasmid in the florescent cells after RMCE 1. 
PCRs on genomic DNA of CHO-K1, “C1” and “C2” for non-S/MAR- and S/MAR-flanks were 
performed as negative controls (-). PCR on the exchange plasmid F3-cmvd2egfp-F was done 
as a positive control (+). M: 1.0 kb marker. 
The positive PCR results above underline the complexity of the cell mixture after RMCE 1 by 
Ganc counter-selection. First of all, not only RMCE-targeted d2egfp, but also randomly 
integrated d2egfp genes contributed the fluorescence of the cell mixture. Secondly, the 
counter-selection with Ganc was insufficient to kill all non-exchanged parental cells, which led 
to the spontaneous resistance of Ganc via epigenetic silencing. Therefore we have to deal 
with different integrations of exchange cassette contributing the fluorescence of the cell 
mixtures:  
 only RMCE-targeted integration of the d2egfp gene, i.e. the expected targets 
 only randomly integrated d2egfp gene into cells containing inactivated tk gene that 
causes Ganc-resistance  
 both targeted and random integration of the d2egfp gene.  
With the conventional RMCE strategy, intense screening has to be performed to recover the 
desired events, but both the complexity of the cell mixture and an unknown exchange rate will 
require tedious and time-consuming work to isolate the correct targets. Therefore, the second 
round of RMCE was introduced to circumvent these problems. 
M    1    2    3    4    5     6   M
 
900 bp 
1. CHO-K1 (-) 
2. pF3-cmvd2egfp-F (+) 
3. C1 (-) 
4. 10/06-C1-S 
5. C2 (-) 
6. 10/06-C2-S 
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2.2.4. Second round of RMCE in Strategy I 
The second round of RMCE (RMCE 2) is presented in Fig 2.6A for non-S/MAR- (left) and 
S/MAR-flanked cells (right) respectively. In order to isolate the RMCE-positive cells from the 
mixture, the hygtk fusion gene was used once more to restore the initial situation during the 
second round of RMCE. The replacement of the tk- by a pgk-promoter on the exchange 
cassette was included to distinguish the exchanged hygtk cassette from the parental hygtk 
cassette. 3 μg exchange plasmid F3-pgkhygtk-F and 1 μg pFlpe were co-transfected into 
“10/06-C1-S” and “10/06-C2-S” cells, respectively. In addition, a transfection without pFlpe 
was performed in parallel as a negative control. In this case, a neutral plasmid, BSpac-Δp (de 
la Luna et al. 1988), encoding Puromycin expression only was co-transfected to compensate 
for variations in the total amount of DNA and transfection agent. One day post-transfection the 
cells were transiently treated by 2.5 μg/ml Puromycin for the reasons delineated in chapter 
2.2.3. Three days post-transfection, the cells were passaged into the medium containing 650 
U/ml Hygromycin. After ~10-14 days, colonies that survived from Hygromycin selection were 
recovered.  
The cells transfected without pFlpe (-Flp) grew as fast as those with pFlpe co-transfection 
(+Flp), which indicated that the phenomenon was mostly due to a randomly integrated 
exchange vector causing the Hygromycin resistance. After reaching confluence, cells were 
suspended for FACS analysis. The expression pattern for the non-S/MAR- and 
S/MAR-flanked cases with and without pFlpe co-transfection, respectively, is shown in Fig 
2.6B. For non-S/MAR-flanked targets, there was no difference between +Flp cells and -Flp 
cells, which indicated that a consistent exchangeability for the cells that underwent RMCE 1 
was not granted. Remarkably, however, for S/MAR-flanked targets, there was a population of 
non-fluorescent cells arising from the action of pFlpe, which indicated the continuous 
exchange of the same locus (loci) targeted in RMCE 1. In order to detect the authentic 
exchange events within this candidate population (L), PCR was performed with primer pairs 
p2494/p2822 for non-S/MAR-flanked targets and p1452/p2822 for S/MAR-flanked targets, 
which were directed towards the pgk promoter, as indicated in Fig 2.6A. As expected, only 
cells with S/MAR-flanked targets gave rise to a positive ~1.0 kb band on the PCR gel (data not 
shown), which was consistent with the results from FACS analysis. 
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Figure 2.6: Second round of RMCE in Strategy I 
A: The exchange cassette containing the hygtk gene under control of a pgk promoter (Ppgk) was 
co-transfected with pFlpe (+Flp) into “10/06-C1-S” and “10/06-C2-S” cells, respectively. A 
transfection without pFlpe (-Flp) was used as a negative control. B: FACS was used to evaluate the 
expression pattern of cells surviving Hyg selection. The S/MAR-flanked cells (right column), which 
were co-transfected with pFlpe (44/06+Flp), were split, by FACS, into a highly fluorescent population 
(H) and a non-fluorescent population (L). Clonal cells were isolated from the ―L‖ population. C: PCRs 
were performed as for ―A‖ on the genomic DNA of pFlpe co-transfected and Hyg-selected cell 
mixture (“44/06+Flp”, ―H‖ and ―L‖ population) and on isolated single clones. Negative controls were 
performed with H2O, “C2” and non-pFlpe co-transfected and selected cells (“44/06-Flp”). Repetition 
of the same experiment with pFlpe co-transfection was performed as a positive control. M: 1.0 kb 
marker. 
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Therefore, after two rounds of consecutive RMCE, the exchangeable cells that gained 
fluorescence only by targeted integration of d2egfp through RMCE 1 have lost the 
fluorescence by a successful replacement of the d2egfp with a hygtk fusion. The 
S/MAR-flanked cell mixture +Flp co-transfection was designated ―44/06+Flp‖, the one -Flp 
―44/06-Flp‖. Consistently exchangeable cells were enriched and single clones from the 
non-fluorescent population of ―44/06+Flp‖ were screened by FACS (Fig 2.6B). 
2.2.5. Characterization of single clones screened after two 
consecutive RMCEs by PCR and Southern blot analysis 
First of all, “44/06+Flp” cells were dissected, by FACS, into two populations, the 
non-fluorescent population (L) and fluorescent population (H; see Fig 2.6B). To verify 
authentic RMCE events, the PCR indicated in Fig 2.6A was performed on both populations 
and on the cell mixture (Fig 2.6C). PCR on genomic DNA of “44/06-Flp” was performed as a 
negative control. An authentic exchange band was found only for the non-fluorescent 
population (L) but not for the fluorescent population (H). The reason for the survival of 
population ―H‖ as well as of cells without pFlpe co-transfection (“44/06-Flp”) from Hyg 
selection is probably due to the random integration of the exchange vector F3-pgkhygtk-F, 
which has led to Hygromycin resistance. Among the non-fluorescent population (L), 59 single 
clones were screened by limited dilution. The same PCR was performed to detect the 
authentic exchange events in the screened single clones, among which 34 showed authentic 
exchange events. The PCR result of 5 representative clones is shown in Fig. 2.6C. PCRs on 
H2O and “10/06-C2-S” cells were performed as negative controls. A repetition of the same 
experiment (with pFlpe co-transfection) served to generate a positive PCR control. 
In chapter 2.2.3, a silenced parental tk gene was found in the potentially targeted cells after 
the first round of RMCE. Therefore we wondered whether the screened single clones after 
RMCE 2 also bear copy(ies) of the parental hygtk cassette. In order to clarify this point, a 
primer pair p2834/p2471 was designed such that the forward one (5’-) resided upstream of 
the F3 site in the parental cassette and the backward one (3’-) in the hygtk gene, as shown in 
Fig 2.7A. Therefore we would be in the position to detect both, a silenced parental F3-hygtk-F 
cassette and an exchanged F3-pgkhygtk-F cassette. These situations can be distinguished 
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due to the different sizes of the tk- relative to the pgk-promoter by PCR amplification. 
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Figure 2.7 Characterization of single clones isolated from the “L” population of “44/06+Flp” 
by PCR and Southern-blot analyses 
A: Genomic DNA of single clones screened in Fig 2.6B was digested with SpeI. SpeI introduces a 
single cut in the parental cassette but cuts twice in the exchanged cassette. B: PCRs were performed 
as for ―A‖ on “44/06+Flp”, separated ―L‖ and ―H‖ populations and on isolated single clones. PCRs with 
H2O, “10/06-C2-S”, CHO-K1 wt cells and “44/06-Flp” cells were performed as negative controls (-). C: 
Hybridization with a tk-specific probe (a) on SpeI-digested genomic DNA of single clones 51 ~ 57 
was used to confirm an authentic exchange reaction (2.6 kb) and a single copy of non-exchanged 
parental cassette (>5.1 kb, single band). D: Hybridization with an S/MAR-E-specific probe (b) served 
to detect a single copy integration of the exchanged cassette (>2.9 kb, single band) and to probe for 
a single copy of the parental cassette (>5.1 kb, single band) that might be left in each single clone.  
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Consistently, a band of 770 bp was found for the exchanged cassette in all the clones that 
showed authentic exchange (with primer pair p1452/p2822 in Fig. 2.6C). Surprisingly, 
however, a band of 405 bp for the parental cassette was also found in all single clones that 
showed an authentic exchange event. Figure 2.7B contains the PCR result for five examples 
of the single clones as analyzed in Fig 2.6C. PCRs on CHO-K1 cells, “10/06-C2-S” and 
“44/06-Flp” served as negative controls. Therefore, among the authentic exchange clones, 
there are silenced parental copies left in the genome, which might have caused 
non-anticipated recombination events that interfere with the expression of the targeted 
cassette due to the existence of multiple copies of the hygtk gene. 
So far, the characterization has concentrated on the existence of authentic exchange events 
in the screened single clones but not on the actual copy numbers of the target. PCR results 
showed that the exchanged hygtk cassette and the silenced parental hygtk cassette 
co-existed for 34 out of 59 single clones. In order to determine the copy numbers of the 
exchanged hygtk and the parental hygtk, Southern-blot analysis was performed on the 
genomic DNA of the single clones (Fig 2.7C and D). First, genomic DNA of the single clones 
were digested with SpeI: SpeI cuts once downstream of the F site on the parental hygtk 
cassette but cuts twice in the exchanged hygtk cassette (downstream of the F site and in the 
pgk promoter, as shown in Fig 2.7A). The first hybridization was performed with a tk-specific 
probe to determine the RMCE-mediated integration of the hygtk cassette. Fig 2.7C shows the 
hybridization pattern of PCR positive clones 51,52,53,54,55,56,57. A defined 2.6 kb band 
indicates the exchanged hygtk cassette but yields no information about the copy number. A 
single band >5.1 kb indicates a single copy integration of the silenced parental cassette left in 
the genome of each single clone. In order to determine the copy number of the exchanged 
cassette, a second hybridization with an S/MAR-E-specific probe was performed on the same 
membrane after stripping. As shown in Fig 2.7D, a single band >5.1 kb confirmed a single 
copy integration for the silenced parental cassette, while a single band >2.9 kb indicated a 
single copy integration of the exchanged cassette. Therefore, combining two hybridizations on 
the same DNA samples, a single copy of parental cassette and a single copy of exchanged 
cassette were found in all the authentically exchanged single clones. Nevertheless, the 
diversity among these clones was very low according to the similar hybridization pattern. 
Although ideal clones with a unique target site were not found, clones with at least one copy of 
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targetable site could be fully characterized. In order to use these lines to generate production 
lines, ―clone 57” was chosen as a master cell line for further RMCE.  
2.2.6. Third RMCE based on the characterized single clones 
As anticipated, production cell lines could be derived from the master lines bearing a unique 
site that is targetable via RMCE. A negative selection with Ganc can eliminate the 
non-exchanged cells due to the expression of the tk gene. But from the results shown in 
RMCE 1, Ganc counter-selection is insufficient to kill non-exchanged cells; it rather leads to 
high ratio of silenced tk genes. Therefore, before exchanging for a GOI, a third RMCE is 
necessary to restore the fluorescent marker, after which the exchange of the GOI can be 
easily distinguished from non-exchanged cells by absence of the fluorescence after targeting. 
2.2.6.1. Third RMCE with positive selection 
Based on its comprehensive characterization in Fig 2.7C and D, ―clone 57” was chosen for the 
third round of RMCE. The strategy is presented in Fig 2.8A.  
The exchange cassette encoding a neomycin (neo) and d2egfp fusion gene (neo-d2egfp) 
under a cmv promoter (Pcmv) was co-transfected into ―clone 57” along with pFlpe. In parallel, a 
transfection without pFlpe was performed as a negative control. After transient selection with 
2.5 μg/ml Puromycin and stable selection with 500 μg/ml G418, only the pFlpe co-transfected 
(+Flp) but not the non-pFlpe co-transfected (-Flp) cells did survive. This indicated the targeted 
integration of neo-d2egfp fusion, which constituted the Neomycin-resistance for the surviving 
cells. FACS analysis was performed to evaluate the expression levels of surviving cells. As 
presented in Fig 2.8B, the majority of these cells showed eGFP expression. In order to verify 
authentic RMCE events, PCR was performed on the survivors with the primer pair 
p2834/pGFP6 shown in Fig 2.8A. As a negative control a PCR on ―clone 57” was performed 
as well. For the survivors, a 1.5 kb band showed the authentic exchange (Fig 2.8C). Due to 
the death of cells without pFlpe co-transfection, in this case there should be very low ratio of 
randomly integrated exchange cassettes. 
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Figure 2.8: The third RMCE on “clone 57” with positive selection 
A: The exchange cassette containing the neo-d2egfp fusion, driven by a cmv promoter (Pcmv), 
was transfected into “clone 57” together with pFlpe (+Flp). As usual, a transfection without 
pFlpe (-Flp) was used as a negative control. The exchange events were selected by G418. B: 
Survivors were only found for +Flpe cells. The expression pattern of the surviving cells was 
evaluated by FACS analysis. C: PCR with the primer pair designated in ―A‖ was performed on 
the surviving +Flp cells. PCR on “clone 57” was used as a negative control. M: 1.0 kb marker. 
2.2.6.2. Third RMCE in the absence of selection 
Our final goal is to perform RMCE without any drug selection. Since ―clone 57” can be 
exchanged under selection pressure, this clone was further exchanged in the absence of any 
drug selection. An experiment corresponding to the one in chapter 2.2.6.1 is presented in Fig 
2.9A. The only difference is that there is no selection marker on the exchange cassette. The 
same control in the absence of pFlpe expression was also performed. 2 days 
post-transfection, the 10-20% highest expressers were collected by FACS, for both pFlpe 
transfected (+Flp) and non-pFlpe transfected (-Flp) cells (data not shown). After the sorted 
cells had grown to confluence, there was no difference between the expression level of +Flp 
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cells and -Flp cells. Therefore a second sorting was conducted to enrich 10% of the highest 
expressing cells again (data not shown). After that, the expression pattern of the 
double-sorted cells was evaluated by FACS analysis (Fig 2.9B). Unfortunately, there was still 
no difference between the +Flp cells and -Flp cells. PCR with the primer pair p2834/pGFP as 
designed in Fig 2.9A was performed on the +Flp cells and -Flp cells, respectively. PCR on 
―clone 57” served as a negative control. Surprisingly, a band of ~900 bp verified the authentic 
exchange event for +Flp transfected cells. Therefore, in the absence of drug selection, RMCE 
is still feasible at the consistently exchangeable site, but the random integration of the 
exchange construct is found to interfere with the authentic targeting event. Under this 
circumstance, the isolation of clones with only targeted integration still involves 
time-consuming, laborious screening processes. 
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Figure 2.9: Third RMCE on “clone 57” in the absence of selection 
A: The exchange cassette with the d2egfp gene driven by a cmv promoter (Pcmv) was 
transfected into “clone 57” along with pFlpe (+Flp). A transfection without pFlpe (-Flp) was 
performed as a negative control. B: High expressers were enriched by two consecutive 
FAC-sortings for cells with and without pFlpe co-transfection. The expression pattern of the 
sorted cells was evaluated by FACS analysis. C: PCR with the primer pair designated in ―A‖ 
was performed on the double sorted cells, depending on pFlpe co-transfection. PCR on “clone 
57” was performed as a negative control (-). M: 1.0 kb marker. 
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2.3. Strategy II  
2.3.1. Overview of Strategy II 
Although Strategy I has been proven to be able to efficiently isolate clones bearing targetable 
sites, it has revealed a number of un-anticipated difficulties discouraging its further use: 
1- the expression of targeted cassette was interfered with randomly integrated exchange 
cassette (Fig 2.5 and 2.9); 
2- the negative selection strategy with Ganc caused too many spontaneous resistance 
events within the transfected and selected cells (Fig 2.3C); 
3- among the cells with multi-copy integrations of the parental cassette, some copies 
turned out to be inactive regarding expression and exchange after counter-selection 
with Ganc. Therefore the selection process is expected to enrich only parental clones 
with a single target site (Fig 2.7); 
4- due to the ineffective negative selection step, a third round of RMCE became 
necessary to mark the master cells with a fluorescent gene. Using this marker the 
targeted cells can be separated by FACS according to the loss of fluorescence after 
the targeted integration of a GOI (Fig 2.8 and 2.9). 
In order to overcome these problems, our optimized Strategy II was developed. As for 
Strategy I, Strategy II is based on two consecutive RMCEs (Fig 2.10). S/MAR elements are 
used to flank the exchange cassette due to the anticipated RMCE-support indicated in Fig 
2.3C and 2.6B. A parental cassette containing the d2egfp gene under control of the cmv 
promoter, with or without S/MAR-E and S/MAR-W elements, is electroporated into CHO-K1 wt 
cells. High expressers can then be collected by FACS. 
Different from Strategy I, a straightforward “promoter trap” principle is employed in which the 
promoter driving the expression of the reporter gene is positioned outside the exchange 
cassette (Seibler and Bode 1997; Lauth et al. 2002), but upstream from the F3-d2egfp-F 
cassette. This situation guarantees that the exchange cassette can only be expressed upon 
targeted integration.  
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Figure 2.10: Overview of Strategy II 
A parental cassette encoding the d2egfp gene under control of the cmv promoter (Pcmv) is 
microporated into CHO-K1 wt cells. Different from Strategy I, the promoter is positioned 
externally from the parental cassette, upstream from the F3 site. Thereby only 
RMCE-mediated integration of the exchange cassette can drive the reading frame of the 
targeted gene. S/MAR elements E and W are used to flank the parental cassette to shield the 
target from heterochromatization and to increase RMCE potential by its strand-separation 
propensity. The parental cassette without S/MARs is used for comparison. High d2eGFP 
expressers can be enriched by FACS multi-sorting. Following these steps, a promoter-less 
exchange cassette containing the hygtk fusion is used to replace the d2egfp gene (RMCE 1). 
Potentially targeted cells can be collected by FACS due to the abolishment of fluorescence. In 
RMCE 2, a promoter-less exchange cassette containing the egfp-tk-neo (GTN) fusion is used 
to restore the initial fluorescence expression. High expressers can be screened via their 
fluorescent intensity. Finally, the clones with a single copy integration of the target and 
consistent exchangeability are chosen to develop production cell lines for various GOIs.  
In the first round of RMCE, a promoter-less exchange cassette containing a hygtk fusion is 
used to replace the d2egfp gene in the parental cells. Due to the simultaneous disappearance 
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of the fluorescence, the potentially targeted cells can then be collected by FACS for RMCE2. 
At the same time the cells bearing a single copy integration of the target will be enriched. 
Consequently, only the cells bearing a single copy of the parental cassette (or multiple copies 
integration, which are all replaced by F3-hygtk-F) will lose their fluorescence entirely. In the 
second round of RMCE, a promoter-less exchange cassette containing a fusion GTN gene 
encoding eGFP, TK and Neomycin protein is used to replace the hygtk fusion. The 
fluorescence is restored upon targeted integration of the GTN fusion by RMCE. To this end, 
the highest expressers can be screened and characterized to achieve variable master cell 
lines with the single copy integration at a unique targetable site that has undergone two 
rounds of RMCE. Master lines containing a single copy of the F3-GTN-F construct driven by 
the cmv promoter can then be used directly for the generation of production cell lines. The 
replacement of F3-GTN-F by various GOIs can be counter-selected by Ganc due to the tk 
gene in the master cells and/or collected by FACS due to the abolishment of fluorescence. 
This optimized strategy was specifically designed to overcome the problems that had become 
apparent in Strategy I: 
Purpose 1: to overcome the interference from random integration(s) of the exchange 
plasmid. In the initial strategy, random integration(s) of the exchange cassette 
F3-cmvd2egfp-F not only contributed to the fluorescence of the cells but could also 
constituted a secondary target site for further rounds of RMCE. This is why the ―promoter trap‖ 
strategy (Fig 2.10) was employed, in which the promoter that originally resided between the 
F3 and F sites is positioned upstream from the F3 site. Therefore, using a promoter-less 
exchange plasmid and a Flp expression plasmid, the exchange construct will be expressed 
only upon correct RMCE-mediated integration (or the adventitious integration downstream 
from an endogenous promoter, which, however, is a rare event). Therefore a random 
integration of the exchange plasmid will impede the transcription of the contained cassette. In 
case of a random integration, the exchange cassette will in no case be strongly expressed, 
which reduce the interference with the expression of the targeted cassette. 
Purpose 2: to enrich the cells with single copy integration of the target. For Strategy I, 
there was no selection step to enrich cells with a single copy target. For the existing studies, 
the selection of such clones had to rely on the screening of numerous individual clones 
derived by different gene transfer techniques (Baer et al. 2000), but even in this case the 
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considerable efforts do not guarantee a success. With the present Strategy II, in the first round 
of RMCE the cells lose their fluorescence only upon total replacement of F3-d2egfp-F by 
F3-hygtk-F, regardless of whether we have to deal with single- or multi-copy integration of the 
parental cassette. Cells for which only some copies of the parental construct have been 
replaced will still keep the expression of the fluorescent marker and can be eliminated by 
FACS. Therefore the cells with a single copy integration of the exchangeable target or 
multi-copy integrations of exchangeable targets become strongly enriched lending 
themselves for further RMCE. 
Purpose 3: to generate master lines which can be directly used for the development of 
production cell lines through different means of selection processes. For Strategy I, the 
master cell lines contain a F3-hygtk-F cassette, meaning that Ganc counter-selection is the 
only way to enrich RMCE-positive cells. However, as indicated in the first round of RMCE, 
Ganc counter-selection is insufficient to eliminate all non-exchanged parental cells - it rather 
leads to a high proportion of cells with a silenced tk gene. If the negative selection is omitted, 
the targeted cells cannot be distinguished from non-exchanged master cells in the absence of 
a drug selection. Therefore a third round of RMCE becomes necessary to mark the master 
cell lines with fluorescence once more for further exchange of GOIs, which can then be 
distinguished from non-exchanged master cells by FACS (Fig. 2.8). In order to circumvent this 
third round, we start the first round of RMCE with parental cells that are already marked with a 
fluorescent gene. In this case the targeted cells end up with the fluorescent marker gene 
already after two rounds of RMCE,. As a consequence, master cell lines can be screened and 
characterized at this stage and can directly be used for the generation of production cell lines. 
In addition, for the master cell lines persistence of the expression level can be continuously 
verified by the intensity of fluorescence. Finally production cell lines with targeted integration 
of the GOI can be directly collected by FACS due to their loss of fluorescence. As a security 
matter the egfp-tk-neo fusion gene provides the additional option to select the targeted cells 
by Ganc counter-selection due to the expression of tk gene. 
In summary, Strategy II, along with two rounds of consecutive RMCEs, has the potential to 
enable the efficient isolation of clones with a high expression level and a consistent 
exchangeability. 
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2.3.2. Establishment of parental cells in Strategy II 
In order to evaluate the expression level for different integration sites under natural conditions, 
the parental cells were generated in the absence of drug selection. 5 μg DraIII linearized 
plasmid cmvF3-d2egfp-F or AscI linearized EcmvF3-d2egfp-FW (Fig 2.11A) was transferred 
into 5E5 CHO-K1 wt cells by a Microporator. The microporated cells were expanded in T75 
flask with normal medium. Two days after microporation, 2% of the highest d2GFP expressing 
cells were collected, by FACS, both for the non-S/MAR- and S/MAR-flanked situations (Fig 
2.11B). In T75 flasks, confluence was reached within 5 days, after which the second sorting 
was performed to enrich for the top 10% of d2GFP expressing cells (Fig 2.11C). Sorted cells 
were designated “13/08-C1” and “13/08-C2” for non-S/MAR- and S/MAR-flanked cells, 
respectively (Fig 2.11D). The expression level of “13/08-C1” and “13/08-C2” was regularly 
evaluated by FACS analysis. For both cases an overlay analysis was performed at passages 
1, 4 and 26 (Fig 2.11E). Since highly active transcriptional sites had been enriched by 
double-sorting, at early passages the expression levels were comparable due to the same 
enrichment process. However during long term culture, the S/MAR-flanked cells turned out to 
be more stable since fewer cells were silenced compared with the non-S/MAR-flanked cells. 
This confirms earlier observations that S/MARs can protect the transgene from the repressive 
effects of a heterochromatic environment and maintain the expression level during long term 
culture. 
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Figure 2.11: Establishment of parental cells in Strategy II 
A: A DraIII-restricted non-S/MAR-flanked parental plasmid, cmvF3-d2egfp-F, or a related 
AscI-restricted S/MAR-flanked parental plasmid EcmvF3-d2egfp-FW was microporated into CHO-K1 
wt cells, respectively. B: Two days post-microporation 2% of the highest d2eGFP expressers were 
collected by FACS. C: After the sorted cells had reached confluence, the second sorting step was 
performed to enrich 10% of the highest expressing cells. D: The expression pattern of double-sorted 
cells is shown, (non-S/MAR- and S/MAR-flanked cells are designated “13/08-C1” and “13/08-C2”, 
respectively). E: The expression stability of “13/08-C1” and “13/08-C2” was evaluated by an overlay 
analysis of the expression level at different generations (passage 1, 4 and 26). 
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2.3.3. First round of RMCE in Strategy II 
The first round of RMCE in Strategy II is presented in Fig 2.12A for non-S/MAR- and 
S/MAR-flanked parental cells, respectively. 3 μg of exchange vector F3-hygtk-F(w/p), 
containing a promoter-less hygtk fusion gene, was co-transfected together with 1 μg pFlpo 
(expressing ―flpo-pac‖) into “13/08-C1” and “13/08-C2” cells (Fig 2.12B). Flpo is a 
mouse-codon optimized Flp-variant, with recombination efficiencies similar to Cre (Raymond 
and Soriano 2007). A RMCE negative control (performed in the absence of pFlpo) was done 
in parallel, for which a neutral DNA only encoding Puromycin (―BSpac-Δp‖) was co-transfected 
to adjust the same ratio of DNA and transfection agent. For the reason indicated in chapter 
2.2.3., the cells were transiently selected with 2.5 μg/ml Puromycin for two days, starting one 
day post-transfection. 3 days post-transfection, an appropriate number of cells were 
passaged into medium containing 650 U/ml Hygromycin. After 5 days, colonies had grown for 
the pFlpo co-transfected cells (+Flp) but not for the non-pFlpo co-transfected cells (-Flp; see 
digital microscopic pictures in Fig 2.12C), indicating that the survivors were probably due to 
targeted integration of the hygtk gene downstream from the cmv promoter, which drives the 
expression of the hygromycin gene. The pooled non-S/MAR- and S/MAR-flanked cells were 
named “17/08-C1” and “17/08-C2”, respectively. The expression patterns of “17/08-C1” and 
“17/08-C2” were evaluated by FACS analysis. For both cell mixtures, a large population of 
non-fluorescent cells emerged (Fig 2.12D), which is the second point of evidence for 
RMCE-mediated integration. The survival of some fluorescent cells may be a consequence of 
only partial integration(s) of the hygtk gene into cells with multi-copies of parental cassettes. In 
theory, targeted integration of only one copy of exchange cassette is sufficient to constitute 
the Hyg-resistance, while the rest copies of parental cassette can keep the fluorescence 
expression. Therefore the non-fluorescent population ―L‖ of each cell mixture was isolated by 
FACS (Fig 2.12D) and designated “17/08-C1-L” and “17/08-C2-L” respectively (Fig 2.12E). 
Meanwhile, the fluorescent population ―H‖ was isolated as well. 
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Figure 2.12: First round of RMCE in Strategy II 
A: Schematic presentation of RMCE 1 in Strategy II: The promoter-less exchange plasmid containing 
the hygtk fusion gene was co-transfected into non-S/MAR- and S/MAR-flanked cells (“13/08-C1” and 
“13/08-C2”) along with pFlpo (+Flp). A transfection without pFlpo (-Flp) was used as a negative 
control. B and C: For cells surviving Hygromycin selection, photos were taken under a microscope. D: 
FACS analyses were performed on the survivors for “17/08-C1” and “17/08-C2”, i.e. on pFlpo 
co-transfected cells. Populations of non-fluorescent cells (L) as well as high fluorescent cells (H) for 
“17/08-C1” and “17/08-C2” were separated by FACS and expanded under Hygromycin for PCR 
analyses and subsequent RMCE reactions. 
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In order to verify authentic exchange events in the Hyg-resistant cells, PCRs were performed 
with the genomic DNA of “17/08-C1” and “17/08-C2” cells, respectively. Primer pairs were 
designed such that the forward one (5’-) was positioned upstream from the cmv promoter and 
the backward one (3’-) within the exchange cassette, as indicated in Fig 2.12A for the primer 
pairs 2546/p2471 (“17/08-C1”) and p1515/p2741 (“17/08-C2”). PCRs on the genomic DNA of 
parental cells “13/08-C1” and “13/08-C2” were performed as negative controls. Unique bands 
of ~800 bp for non-S/MAR-flanked cells and of ~1.5 kb for S/MAR-flanked cells were found on 
the PCR gel (Fig 2.13). The same PCR was performed on the sorted sub-populations, ―L‖ and 
―H‖, for non-S/MAR- and S/MAR-flanked cells respectively.  
         
 
 
 
Figure 2.13: Characterization of authentic exchange events after RMCE 1 by PCR 
analyses 
PCR was performed as for Fig 2.12A to verify authentic exchange events for “17/08-C1”, 
“17/08-C2” and the ―L‖ and ―H‖ populations collected by FACS after RMCE 1. PCRs with H2O 
and the parental cells (“13/08C1” and “13/08-C2”) were performed as negative controls (-). M: 
1.0 kb marker. 
Positive results from PCR indicated authentic exchange events among the non-fluorescent 
population (L) as well as partially targeted integration of the hygtk gene in the fluorescent 
population (H). The non-fluorescent population “17/08-C1-L” for non-S/MAR-flanked cells and 
“17/08-C2-L” for S/MAR-flanked cells were expanded for the second round of RMCE. 
In order to verify our initial expectation that RMCE can be performed in the absence of any 
selection pressure, the transfected cells were not further selected with Hygromycin after the 
transient selection step in Puromycin but were rather expanded directly into normal medium. 
PCR was performed as described above on genomic DNA of pFlpo co-transfected and 
1. H2O (-) 
2. 13/08-C1 (-) 
3. 17/08-C1 
4. L population of 17/08-C1 
5. H population of 17/08-C1 
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3. 17/08-C2 
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non-pFlpo co-transfected cells. Authentic exchange bands were neither found for unselected 
cells with pFlpo co-transfection nor without pFlpo transfection (data not shown). Therefore, if 
RMCE has been performed on cell mixtures, drug selection is still necessary in order to enrich 
for authentic events.  
2.3.4. Second round of RMCE in Strategy II 
The second round of RMCE in Strategy II is presented in Fig. 2.14A, again for non-S/MAR- 
and S/MAR- flanked cells. 3 μg of exchange vector containing a promoter-less egfp-tk-neo 
(GTN) fusion gene, ―F3-GTN-F(w/p)‖, was co-transfected along with 1 μg pFlpo (+Flp) into 
“17/08-C1-L” or “17/08-C2-L” cells (Fig 2.14B). The same negative control (-Flp) used for 
RMCE 1 was performed in parallel. After selection with 2.5 μg/ml Puromycin for 2 days, the 
transfected cells were pooled in medium containing 500 μg/ml G418. For +Flpo cells, colonies 
became apparent after 7 days under G418 pressure, while very few colonies survived in case 
of -Flp cells. This difference was documented by digital photos taken under the microscope 
(Fig 2.14C). The survival of a few colonies in -Flp cells was due to the fact that the cryptic 
promoter sequence in the ampicillin gene initiated some expression of the GTN fusion, which 
became evident from the transient expression of eGFP on F3-GTN-F(w/p) in CHO-K1 wt cells 
(data not shown). After the surviving cells had grown to confluence, the expression pattern 
was evaluated by FACS analysis, as shown in Fig 2.14D. Both for non-S/MAR- and 
S/MAR-flanked cells, a population of fluorescent cells was detected only for the +Flpo case, 
which indicated the RMCE-dependent targeted integration of the GTN fusion downstream 
from the cmv promoter. A few weak eGFP expressers were also detected for the -Flp case, 
which is likely due to random integration of exchange cassettes next to a cryptic promoter. 
Since only high expressers are of interest for the generation of production cells, 10% of the 
highest eGFP expressing cells (H) were selected by FACS. Some portion of the 
non-fluorescent population (L) was collected for control purposes. In order to further prove 
that expression of eGFP in the +Flp case can be ascribed to the authentic RMCE-mediated 
integration of the GTN fusion, PCR was performed as indicated in Fig. 2.14A. Primer pairs 
were designed such that the forward one (5’-) was posed upstream from the cmv promoter 
and the backward one (3’-) within the exchange cassette as indicated (p2546/p1513 for 
non-S/MAR-flanked cells and p1452/p1513 for S/MAR-flanked cells). PCRs on “17/08-C1-L”,
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“17/08-C2-L” and -Flp cells were used as negative controls both for non-S/MAR- and S/MAR-flanked 
cells respectively.  
 
p2546 p1513
2.9 kb
p1452 p1513
2.8 kb
RMCE 2
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14: Second round of RMCE in Strategy II 
A: Schematic presentation of RMCE 2 in Strategy II: The promoter-less exchange plasmid containing 
the GTN fusion gene was co-transfected into non-S/MAR- and S/MAR-flanked cells (“17/08-C1-L” 
and “17/08-C2-L”) , along with pFlpo (+Flp), respectively. A transfection without pFlpo (-Flp) served 
as a negative control. B and C: For cells surviving G418 selection, digital photos were taken under a 
microscope. D: FACS analyses were performed on the survivers, both for cells with and without 
pFlpo co-transfection. The populations of highly fluorescent cells (H) and of non-fluorescent cells (L) 
were separated by FACS. Single clones were isolated from the ―H‖-populations both for non S/MAR- 
and S/MAR-flanked cells respectively. 
B 
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M  1   2   3    4   5 M  1    2    3   4    5
Fig 2.15 demonstrates that authentic exchange events could be detected for the +Flp cases 
as well as for the separated ―H‖ and ―L‖ populations, but not for the negative controls. The 
authentic exchange events in the ―L‖ population were likely due to the integration of the GTN 
fusion, which was silenced. To verify this assumption, single clones from the ―H‖ population of 
non-S/MAR- and S/MAR-flanked cells were screened and characterized. 
 
 
 
 
 
Figure 2.15: Characterization of authentic exchange events after RMCE 2 by PCR 
The primer pairs were designed as for Fig 214A. For both non-S/MAR- and S/MAR-flanked 
cells, PCRs were performed for pFlpo co-transfected cells (+Flp) surviving G418 selection. 
The populations were split into ―H‖- and ―L‖-fractions. PCR reactions on cells surviving G418 
in the absence of pFlpo co-transfection (-Flp) as well as on “17/08-C1-L” and “17/08-C2-L” 
were used as negative controls. M: 1.0 kb marker. 
2.3.5. Characterization of single clones screened after two 
consecutive RMCEs in Strategy II 
2.3.5.1. Characterization of the single clones by PCR and 
Southern-blot analyses 
After RMCE 2, 24 single clones of each were isolated by FACS from the ―H‖ population of 
non-S/MAR- and S/MAR-flanked cells. The non-S/MAR- and S/MAR-flanked single clones 
were numbered “C1-1” to “C1-24” and “C2-1” to “C2-24”, respectively. According to FACS 
analysis, each single clone showed homogenous eGFP expression. Evaluation of the 
expression stability in long term culture will be described in chapter 2.3.5.2 below. In order to 
verify an authentic exchange event within a single clone, the same PCR indicated in chapter 
2.3.4 was performed. PCR on the cell mixture was performed as a positive control. PCR 
results of 11 representative clones for non-S/MAR- and S/MAR-flanked cells are presented in 
Fig 2.16A and prove that, in fact, all non-S/MAR- and S/MAR-flanked clones showed 
1. 17/08-C1-L (-) 
2. Cells transfected 
without pFlpo (-Flp) 
3. Cells transfected with 
pFlpo (+Flp) 
4. L population 
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2.9 kb 2.8 kb 
1. 17/08-C2-L (-) 
2. Cells transfected 
without pFlpo (-Flp) 
3. Cells transfected with 
pFlpo (+Flp) 
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authentic exchange events.  
In order to determine the copy number(s) of the target site(s), Southern-blot analyses on the 
genomic DNA of the single clones were performed in parallel. In all cases the genomic DNA 
was digested with NheI, which cuts twice in the targeted cassette (within the cmv promoter 
and within the GTN fusion gene; see Fig 2.16B). NheI also cuts once within the exchange 
plasmid F3-GTN-F(w/p). The hybridization with a cmv-specific probe was the first to be done. 
Since the cmv promoter is derived from the parental cells, the number of unique hybridization 
bands reflects the number of targeted sites for individual clones. Fig 2.16C shows integration 
unique integration site for non-SMAR-flanked clones, except for clones “C1-2” and “C1-13”. 
For S/MAR-flanked clones, all proved a single integration site. Although the clone diversity of 
S/MAR-flanked clones appears to be very low according to the similar hybridization patterns 
among the 24 clones, this criterion is not sufficient to conclude that these clones are identical: 
S/MARs may have directed the respective vectors to a unique class of loci, for instance 
repetitive DNA. The hybridizations on parental cells, “13/08-C1” and “13/08-C2”; the cells for 
RMCE 2, “17/08-C1-L” and “17/08-C2-L”; and the non-pFlpo co-transfected cells in RMCE 2 
were performed as negative controls for non-S/MAR- and S/MAR-flanked clones respectively.  
Since after G418 selection there were some weakly eGFP-expressing cells detected for the 
non-pFlpo co-transfected population, randomly integrated exchange cassettes under control 
of cryptic promoter sequences for the pFlpo co-transfected cells might also exist. Therefore 
Southern blot analyses were conducted to define the contribution of RMCE-mediated or the 
random integration events (or both) to GFP expression. A gfp-specific probe was used to 
hybridize the samples on the membrane after stripping. A defined 2.7 kb band indicates the 
RMCE-mediated integration of the exchange cassette. If there is extra random integration(s) 
of the exchange cassette, a band >2.7 kb would be detected. If there remained a silenced 
parental cassette (F3-d2egfp-F) in the single clones (comparable to Strategy I), extra bands 
would be detected as well. In order to exclude the latter possibility, 24 single clones after 
RMCE 1, each for non-S/MAR- and S/MAR-flanked cells within “17/08-C1-L” and 
“17/08-C2-L”, were screened. PCR with a primer pair specific for the parental cassette 
(F3-d2egfp-F) was performed on these single clones. We conclude that none of the single 
clone contains any silenced parental cassette after RMCE 1 (F3-d2egfp-F; data not shown). 
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Figure 2.16: Characterization, by PCR and Southern-blot analyses, of the single clones 
resulting from RMCE 2  
A: PCR was performed on 11 single clones selected from non-S/MAR- or S/MAR-flanked populations 
as indicated in Fig 2.14A. PCR on the corresponding clone mixture was performed as a positive 
control. B: Single clones isolated after RMCE 2 were digested with NheI. C: The digested single 
clones were hybridized with a cmv-specific probe. D: The digested single clones were hybridized with 
a gfp-specific probe after stripping. Corresponding hybridizations on parental cells (“13/08-C1” and 
“13/08-C2”), cells for RMCE 2 (“17/08-C1-L” and “17/08-C2-L”) and on non-pFlpo co-transfected 
(-Flp) cells in RMCE 2 were performed as negative controls, both for non-S/MAR- and 
S/MAR-flanked clones.
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Data in Fig 2.16D show that, among 24 non-S/MAR-flanked single clones, a 2.7 kb band was 
found in all cases confirming the authentic exchange events that had already been concluded 
from the PCR results (Fig 2.16A). Moreover, only clone “C1-7” did contain one extra copy of a 
randomly integrated exchange cassette.  
Among 24 S/MAR-flanked single clones, a 2.7 kb band was found throughout. However, clone 
“C2-4”, “C2-6” ~ “C2-9”, “C2-11”, “C2-15”, “C2-18” ~ “C2-24” harbored an extra copy of 
randomly integrated exchange vector in addition to the targeted site.  
Combining with the first hybridization with the cmv-specific probe, a single copy has been 
integrated at the unique target site existing in all of screened single clones (except “C1-2” and 
“C1-13”). For these, loss of fluorescence (transition from d2egfp to hgytk in RMCE 1) and 
regain of fluorescence (transition from hgytk to GTN in RMCE 2) could be traced through two 
consecutive RMCEs. “C1-2” and “C1-13” contained two target sites. PCR with a primer pair 
specific for the F3-hgytk-F cassette was performed on each (data not shown). Neither of these 
two single clones still harbored the hygtk gene showing that both potential targets were 
addressed in RMCE 2.  
Since our main interest concerns clones with a unique targetable site, all clones with 
multi-copy integrations of parental cassettes and random integrations of the exchange 
cassette were excluded for the generation of production cell lines. The remaining clones have 
been summarized in table 2.1. 
Table 2.1: Characterization of single clones remaining after RMCE 2 
 
PCR+ 
Single copy 
integration of 
target site 
Random 
integrations 
of 
exchange 
cassette 
Clone 
diversity 
Suitable clones 
(Master cell lines) for 
development of 
production cell lines 
Non-S/MAR- 
flanked 
24/24 22/24 1/24 High 
Except “C1-2”, “C1-7” 
and “C1-13” 
S/MAR- 
flanked 
24/24 24/24 14/24 Low 
“C2-1” ~ “C2-3”, 
“C2-5”, “C2-10”, 
“C2-12” ~ “C2-14”, 
“C2-16” and “C2-17” 
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2.3.5.2. Expression stability of the single clones in the presence and 
absence of G418 
Since potential production cell lines for various GOIs are derived from the fully characterized 
master cell lines (chapter 2.3.5.1), the expression properties of production cell lines should 
reflect those of the master clones. Therefore both the expression level and stability of these 
clones are important criteria for choosing suitable candidates for further RMCE. Here we have 
FACS-evaluated the expression level of each 24 non-S/MAR- and S/MAR-flanked single 
clones during long term culture in the presence and absence of selection. 
The expression properties of non-S/MAR- and S/MAR-flanked single clones at passage 2, 9 
and 30 in the presence of G418 is shown in Fig 2.17A and Fig 2.18A. The data were 
evaluated as the mean level of GFP expressing cells. All clones had homogenous GFP 
expression properties - most of them maintained a stable expression level over 4-months 
culture in the presence of G418. An overlay analysis was also performed. Some 
representative data have been compiled in Figs 2.17B and 2.18B. For example, for 
non-S/MAR-flanked clones, “C1-1”, “C1-17” and “C1-20” maintain their expression level over 
30 passages, while “C1-12” shows a shift to lower levels. In case of the S/MAR-flanked clones, 
“C2-2”, “C2-19” and “C2-23” keep the expression level stably but “C2-21” shows a decrease. 
Since the expression level of different single clones is mostly related to the genomic 
integration site, the variable expression properties of single clones confirm the presence of 
different integration sites.  
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Figure 2.17: Expression level of non-S/MAR-flanked single clones in the presence of 
G418 
A: The GFP expression level of 24 single clones was measured, by FACS analysis, at 
passages 2, 9 and 30. GFP expression was evaluated as the mean of GFP expressing cells. 
B: The overlay analysis of clone “C1-1”, “C1-17”, “C1-20” and “C1-12” at passage 2 (black 
curve), 9 (green curve) and 30 (red curve).  
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Figure 2.18: Expression level of S/MAR-flanked single clones in the presence of G418 
A: GFP expression level of 24 single clones was measured by FACS analysis at passage 2, 9 
and 30. The GFP expression was evaluated as the mean of the GFP expressing cells. B: 
Overlay analysis of clone “C2-2”, “C2-19”, “C2-23” and ―C2-21” at passage 2 (black curve), 9 
(green curve) and 30 (red curve). 
As anticipated in chapter 2.1, our final goal is to integrate a GOI via RMCE in the absence of 
any drug selection, which means that after RMCE-mediated integration, the transgene is 
expressed under natural conditions. Therefore the expression properties of single clones in 
the absence of selection pressure are essential to choose suitable candidates for further 
modification. For this purpose, variable non-S/MAR- and S/MAR-flanked unique clones were 
selected based on the Southern-blot analyses (Fig.2.16C and D). For non-SMAR-flanked 
single clones, “C1-1, 3, 5, 10, 12, 17, 20, 21, 22” and for S/MAR-flanked clones, “C2-4, 9, 11, 
14, 15, 17, 19, 20, 21, 23, 24” were chosen for continued culture in normal medium over 3 
months. The mean level of the GFP expressing cells was used to evaluate the expression 
level for each single clone (see Fig 2.19A and Fig 2.20A). Different from the single clones 
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growing under selection pressure, not all of the clones showed homogenous expression in the 
absence of G418 over this period of time. Representative results of overlay analyses are 
shown in Fig 2.19B and Fig.2.20B. For instance, non-S/MAR-flanked clones “C1-5, 10, 20” did 
maintain consistent expression levels, but in case of clone “C1-12” a silenced population 
emerged that increased with time. The phenomenon is similar for S/MAR-flanked clones, e.g. 
stable clones “C2-4, 11, 14” and unstable clone “C2-9”.  
Only the stably, homogenously expressing clones will be chosen as master cell lines for 
further development of production lines.  
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Figure 2.19: Expression level of non-S/MAR-flanked single clones in the absence of 
G418 
A: The GFP expression level of 9 single clones was measured, by FACS analysis, at passage 
1, 15 and 25. GFP expression was evaluated as the mean of the GFP expressing cells. B: 
Overlay analysis of clone “C1-5”, “C1-10”, “C1-21” and “C1-12” at passage 1 (black curve), 15 
(green curve) and 25 (red curve). 
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Figure 2.20: Expression level of S/MAR-flanked single clones in the absence of G418 
A: The GFP expression level of 11 single clones was measured by FACS analysis at passage 
1, 15 and 25. GFP expression was evaluated as the mean of the GFP expressing cells. B: 
Overlay analysis of clone “C2-4”,” C2-11”, “C2-14” and “C2-9” at passage 1 (black curve), 15 
(green curve) and 25 (red curve). 
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2.3.6. Improvement of the transcription level of single clones by 
HDAC inhibitors 
As described before, the expression properties of a given transgene in different single clones 
depends on the nature of the genomic integration site. This phenomenon, known as the 
position effect, is a major hurdle in the development of recombinant protein production in 
mammalian cells. In order to circumvent this effect, we used the targeted integration into 
previously characterized transcription-active sites. In addition, we introduced chromatin 
domain bordering elements (S/MARs) to shield the transcription process from the influences 
of surrounding chromatin structures (e.g. heterochromatization). During previous studies, it 
was found that the expression level of a reporter flanked by different S/MAR elements can be 
boosted, by adding a histone deacetylase inhibitor into cluture medium (HDACi; Schlake et al. 
1994). The S/MAR elements serve to organize the histone-acetylation state of an entire 
chromatin. Therefore, some representatives of non-S/MAR- and S/MAR-flanked single clones 
were treated with HDACi such as sodium butyrate (NaBu) or valproic acid (VPA). The 
non-S/MAR-flanked clones “C1-1, 3, 5, 10, 12, 17, 20, 21, 22” and the S/MAR-flanked ones 
“C2-4, 9, 11, 14, 15, 17, 19, 20, 21, 23, 24” were cultured with the medium supplied with 5 mM 
NaBu or 4 mM VPA for two days. The cells were rinsed with PBS and then suspended for 
FACS analysis. Expression levels were evaluated as the mean level for GFP expressing cells. 
For Fig 2.21A and B, the expression levels of untreated cells were normalized, which was set 
to 1. The factor for transcription augmentation is indicated on the bars both for NaBu and VPA. 
Comparison with the non-S/MAR-flanked clones clearly demonstrates that both agents have a 
significantly larger effect if the transgene is present in the form of an autonomously regulated 
unit (chromatin domain). For instance, NaBu augments expression 5-6 fold for most 
non-S/MAR-flanked clones, but 9-10 fold in case of S/MAR-flanked clones. HDACi treated 
cells also showed homogeneity regarding the expression level. As examples, overlay 
analyses are shown in Fig 2.21A and B for the situation before and after adding NaBu both for 
non-S/MAR-flanked clones (“C1-1” and “C1-21”) and S/MAR-flanked clones (“C2-4” and 
“C2-21”).  
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Figure 2.21: Expression level of non-SMAR- and S/MAR-flanked clones with NaBu or VPA 
treatment 
A: Expression levels of non-SMAR-flanked clones “C1-1, 3, 5, 10, 12, 17, 20, 21, 22” without NaBu 
treatment were normalized, i.e. set to 1. The factor for NaBu or VPA is indicated on the bars. Overlay 
analyses on clones “C1-1” and “C1-21”, before and after NaBu treatment are also shown. B: The 
same experiments on S/MAR-flanked clones “C2-4, 9, 11, 14, 15, 17, 19, 20, 21, 23, 24”. Overlay 
analyses on clone “C2-4” and “C2-21”, before and after treating with NaBu are shown for comparison. 
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2.4. Development of production cell lines 
2.4.1. The targeted integration of a GOI via RMCE 3 
After full characterization of the single clones with target-ability and stable expression 
properties, suitable clones were chosen as master cell lines to establish production cell lines 
for various GOIs. Here, non-S/MAR-flanked clone “C1-23” and S/MAR-flanked clones “C2-1” 
and “C2-14” were selected for further development. “C1-23” and “C2-1” were chosen due to 
their high and homogenous expression level, while “C2-14” had an integration site different 
from that of other S/MAR-flanked clones (see Fig 2.16C).  Following our Strategy II, a 
promoter-less bi-cistronic GOI-IRES-pac cassette was constructed on the exchange vector 
F3-GOI-IRES-pac-F. The nature of the GOI cannot yet be made public due to commercial 
reasons. This cassette was co-transfected into the selected master cell lines, together with 
the pFlpo expression construct (Fig 2.22A). This strategy provides three options to enrich for 
the authentic exchange events: 
1 -   negative selection with Ganc to exclude the non-exchanged cells; 
2 - positive selection with Puro to obtain the exchanged cells; 
3 - FAC-sorting of authentic RMCE-events according to the loss of fluorescence. 
A negative control without pFlpo co-transfection was again performed in parallel, along with 
neutral DNA as described above (chapter 2.3.3). In order to test the exchangeability of these 
clones in the absence of drug selection, which is also the fastest way to obtain exchanged 
cells, the transfected cells were passaged into normal medium after transient selection with 
2.5 μg/ml Puromycin for 2 days. FACS analyses were then performed on the pFlpo 
co-transfected cells (+Flp) as well as the non-pFlpo co-transfected cells (-Flp). From Fig 
2.22B, the percentage of non-fluorescent cells in the presence of pFlpo is higher than the 
percentage in its absence. For instance, in clone “C1-23”, there are 4.15% non-fluorescent 
cells with co-transfection of pFlpo (1.24% non-fluorescent cells without co-transfection), which 
indicates that the exchanged (loss-of-fluorescence) cells contribute the higher percentage of 
the non-fluorescent population. 
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Figure 2.22: Third round of RMCE: Development of production cell lines 
A: Schematic representation of an RMCE step to develop production cell lines: a promoter-less 
exchange cassette encoding the GOI-IRES-pac gene was transfected along with pFlpo (+Flp) to 
replace the GTN cassette in the master cell lines. A negative control without pFlpo co-transfection 
(-Flp) was performed in parallel. B: Master cell lines “C1-23”, “C2-1” and “C2-14” were chosen to 
derive GOI production cell lines. After transfection and one following passage, the difference 
between expression pattern of +Flp and -Flp transfected cells was evaluated by FACS analysis. The 
population of non-fluorescent cells was gated and sorted. The expression of GOI was only found in 
the sorted cells +Flp co-transfection, but not in the ones -Flp co-transfection. C: The PCR indicated in 
Fig 2.22A was performed on the sorted cells. PCR on the corresponding master line was performed 
as a negative control. Single clones from the sorted cells +Flp co-transfection were screened by 
FACS.
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In order to prove this point, the non-fluorescent populations of +Flp cells and of -Flp cells were 
isolated by FACS. After expanding the sorted cells, supernatants were taken to measure the 
expression level of the GOI (performed by InVivo). Not surprising, the expression of GOI could 
only be monitored in the supernatants from +Flp cells. For the -Flp case, expression was 
below the detection level (data not shown). Meanwhile the authentic exchange events were 
also verified by PCR (Fig 2.22C) for the sorted, pFlpo co-transfected cells [the primer pair is 
indicated in Fig 2.22A for non-S/MAR- (p2546/p3073) and S/MAR-flanked cells 
(p1452/p3073)]. Sorted GOI expressing cells derived from “C1-23”, “C2-1” and “C2-14” were 
designated “39/08-23”, “37/08-1” and “37/08-14” accordingly. Subsequently, single clones 
were screened from “39/08-23”, “37/08-1” and “37/08-14” to find the high producers with the 
targeted integration of the GOI. 
2.4.2. Screening and characterization of single clones with high 
GOI expression 
In order to identify clones with high GOI expression, each 100 single clones of “39/08-23”, 
“3708-1” and “37/08-14” were screened by FACS. 11 of 100 (―a‖ ~ ―k‖) from “39/08-23”, 11 of 
100 (―a‖ ~ ―k‖) from “3708-1” and 9 of 100 (―a‖ ~ ―i‖) from “3708-14” were found with high GOI 
expression (see Fig 2.23A). The remainder of single clones derived from the corresponding 
master cell lines either had an extremely low or an undetectable expression level (data not 
shown). The PCR shown in Fig 2.22A was performed on all GOI high expressers to verify 
authentic exchange events for single clones. Some representatives derived from 3 master 
lines are shown in Fig 2.23B. All randomly selected single clones showed RMCE-mediated 
integration events. In order to prove the GOI expression is exclusively due to RMCE, 
Southern-blots were performed on some of the single clones, which were selected for PCR 
analysis as indicated in Fig 2.22A. The genomic DNA of single clones was cut with NdeI 
(within the cmv promoter) and NotI (within the GOI; Fig 2.22A), which leads to a defined 950 
bp band upon RMCE-mediated integration (randomly integrated GOI would give rise to 
additional bands). Since there is only one target site in the master cell lines, the 
RMCE-mediated integration of GOI is expected to be unique as well. After hybridization with a 
GOI-specific probe, it turned out that except for one clone (“clone c” derived from master line 
“C1-23”) all others showed a RMCE-mediated integration of the GOI exclusively (Fig.2.23C).  
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Figure 2.23: Characterization of GOI expressing single clones derived from master cell 
lines 
A: The GOI expression level of 11 single clones (―a‖ to ―k‖) from “39/08-23”, 11 single clones 
(―a‖ to ―k‖) from “37/08-1” and 9 single clones (―a‖ to ―i‖) from “37/08-14”. B: PCRs on 
representatives of single clones were performed as designed in Fig 2.22A. PCRs with H2O 
and the corresponding master cell line from which the GOI single clones had been derived 
served as negative controls (-). A PCR on the pool from which the GOI single clones had been 
isolated was performed as a positive control (+). C: Southern-blot analysis was performed on 
some of the single clones as indicated in Fig 2.22A. NdeI/NotI digested single clones were 
hybridized with a GOI-specific probe. The corresponding master cell lines from which these 
single clones were derived were hybridized as negative controls.   
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Hybridizations on the corresponding master cell lines were performed as negative controls, 
clearly demonstrating that GOI expression can be ascribed to the targeted integration event of 
the GOI. The similar expression levels of GOI obtained for single clones from the same 
master line also shows that these are identical.  
Analyses of the single clones derived from three master lines are summarized in table 2.2. 
Table 2.2: The summary of the analysis of GOI expressing clones derived from corresponding 
master lines 
Master cell 
lines 
GOI high 
expressers 
RMCE-mediated 
integration 
exclusively 
Efficiency of screening 
for clones with targeted 
integration 
C1-23 11/100 4/5 8.8% 
C2-1 11/100 4/4 11% 
C2-14 9/100 5/5 9% 
To summarize: with Strategy II, master cell lines with a unique target-able site can be 
efficiently isolated from randomly selected integration sites. These master cell lines show a 
stable and homogenous expression pattern with a consistent retarget-ability in the absence or 
presence of a selection pressure. The production cell lines can be derived from the master 
lines in the absence of any drug selection. The efficiency of isolating high production clones 
with only targeted integration of the GOI is about 10%. 
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3. Discussion 
Targeted integration of a GOI into a pre-identified transcriptional hotspot is a valuable 
approach to counteract the well known unstable and un-predictable expression patterns 
caused by position effects. This concept has enabled a production platform in which the 
transgenic cell line contains a single copy gene at a unique genomic location. Here we 
describe the benefits of a method consisting of two consecutive rounds of RMCE to isolate 
master clones with re-usable hotspots that provide high and homogenous expression 
properties for any GOI. Relying on a ―promoter trap‖ strategy and on FACS counter-selection, 
the production cell lines can be derived in the absence of drug selection. Such a combination 
of complementary selection procedures proves to be largely superior to the traditional 
processes. 
The second approach to augment transcription level of the transgene relies on the use of 
chromatin bordering elements, e.g. S/MARs, to protect the integrated GOI from common 
repressive effects of the genomic environment. These are mostly caused by promoter-DNA 
methylation and histone methylation or hypoacetylation (Bode et al. 2000a; Bode et al. 2003). 
Histone deacetylase inhibitors (HDACi), e.g. sodium butyrate (NaBu) or valproic acid (VPA) 
were used to improve chromatin accessibility and thereby transcription rates by increasing 
histone acetylation levels (Davie 2003; Van Dyk et al. 2003). 
3.1. How to improve RMCE efficiency? 
3.1.1. The molecular basis of RMCE 
The mechanism of RMCE is known to considerable extent (Schlake and Bode 1994; Bode et 
al. 2000b; Oumard et al. 2006). When RMCE was developed by Schlake and Bode (1994), the 
proposed mechanism still involved two possible intermediates that might arise from a single 
reciprocal crossover between identical FRT recombination targets (either F/F or F3/F3 pair) 
on parental and exchange cassettes, respectively (Fig 3.1). Intra-molecular recombination 
between the F/F or F3/F3 sites on the intermediate would then either restore the initial 
situation or lead to the desired exchange of the parental cassette by the GOI. A related 
mechanism was discussed for the Floxing system in which two site-specific recombinases, 
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Cre and Flp were used in combination (Lauth et al. 2002). For this two-step mechanism, the 
excision step would lead to an event corresponding to a net exchange or restore the educts 
reducing the efficiency.  
1
2
Possible Intermediates 1/2
 
Figure 3.1: Two-step mechanism of RMCE (redrawn according to Fig 2 in Schlake and 
Bode 1994) 
Recombination between F/F or F3/F3 pair on the parental and exchange cassettes (according 
to the ―Flp-in‖ principle) leads to two kinds of possible intermediates, which contain the 
insertion of the exchange cassette. According to a stepwise mechanism, the excision between 
F/F or F3/F3 on the intra-molecular intermediate yields the desired product of RMCE (solid 
line) – otherwise the educt-situation is restored (dashed line). 
Ways to improve the rate and extent of RMCE have mainly relied on the improvement of 
recombinase activity, i.e. the increase of collision events between the parental and the 
exchange cassettes. In addition, elaborated selection principles were applied to enrich the 
desired RMCE product (Seibler and Bode 1997; Seibler et al. 1998) 
Since intermediates were never detected for this mechanism (Seibler et al. 1998; Kim and 
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Lee 2008), at least for practical purposes the mechanism can be seen as a simultaneous 
double-reciprocal crossover between the pair of hetero-specific FRT sets on parental and the 
exchange cassettes. All efforts to improve RMCE rates based on the sequential type would 
also apply for this mechanism. 
3.1.2. Improvement of recombinase activity 
There are two principal ways to improve the level of active recombinases, either by increasing 
the amount of transfected enzyme or by creating an optimized enzyme version. 
Initially the thermo-instability of Flp has limited its use for mammalian cells (Buchholz et al. 
1996). After screening for thermo-stable mutants, Flpe was identified and shown to provide a 
4 fold increase in recombination efficiency, which was still low if compared with Cre. Since, at 
the onset of this study, Flpe was the only available variant, it was cloned into a bicistronic 
expression construct flpe-IRES-pac. Transient selection with Puromycin could then serve to 
isolate the cells receiving both, the exchange vector and the Flpe expression vector 
(Taniguchi et al. 1998). In 2007, the de novo synthesis of a mouse codon-optimized Flp 
variant (Flpo) was reported, the recombination efficiency of which resembles Cre (Raymond 
and Soriano 2007). This gave raise to our flpo-IRES-pac vector variant. After transient 
selection in Puro, the recombination efficiency of Flpo proved to be substantially higher than 
Flpe in the same experimental setting (personal communication by S. Turan). Therefore 
flpo-IRES-pac was used for Strategy II throughout. 
Previous studies show that at high concentrations of the recombinase, recombination 
proceeds very quickly and is complete within a few hours (Peitz et al. 2002). Therefore a 
transient expression of Flp is sufficient to induce and complete the process. Due to the 
cytotoxic effects of many transfected DNAs, the ratio of exchange vector and Flp expressing 
vector was optimized and adjusted to 3:1. 
3.1.3. The distance limitation between FRT sites 
Site-specific recombination depends on random collision between two FRT sites. Since the 
parental cassette is a single copy embedded in the host chromatin, increasing the amount of 
the exchange cassette is the only way to raise the rate of random collision. Therefore, the 
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exchange cassette is commonly applied at a large molecular excess. Under these conditions 
RMCE becomes virtually irreversible, according to the mass action principle.  
In case the two FRT sites are positioned on a single naked DNA molecule (e.g. the 
intermediates in Fig 3.1), the distance between the two FRT sites might also influence the rate 
of random collision. On one hand, two FRTs cannot randomly collide when the distance is too 
short (less than approximately 120 bp) because of the inherent stiffness of DNA. On the other 
hand, increased distance leads to a predictable and asymptotic decrease in recombination 
frequencies (Ringrose et al. 1999). Nevertheless, Wallace et al. (2007) described an extended 
strategy (recombinase-mediated genomic replacement, RMGR) that allowed the replacement 
of a large segment (>100 kb) of the mouse genome by the equivalent human synthetic region 
on a bacterial artificial chromosome (BAC) DNA. Since a stringent selection procedure was 
required to enrich the rare recombinants, the exchange of large DNA pieces appears to be 
difficult although recombination events can still be recovered by an appropriate selection 
procedure.  
3.1.4. The position effect of FRT sites on recombination 
efficiency 
Different integration sites in a genomic context can lead to variable expression levels for the 
same transgene (―position effect‖). This phenomenon has also been reported to influence the 
recombination efficiency between two FRT sites (Vooijs et al. 2001). Similar to the incomplete 
understanding of position effects on gene expression, to what extent recombination is affected 
by chromatin environments is also unclear. The conventional way to identify integration sites 
with RMCE-competence is to tag them with a set of hetero-specific FRTs, and then test the 
exchangeability of the enclosed expression cassette (the called ―tag and exchange‖ strategy 
according to Seibler et al. 1998). Along these lines, a panel of single clones with single copy 
integration of a parental cassette flanked by F and F3 sites at different loci was tested for the 
exchangeability under the same conditions (Qiao, master thesis, 2005). It proved to be true 
that not every integration locus can be targeted with a given exchange cassette. Therefore an 
identification process is standard and it has to rely on extensive screening.  
In this situation, we developed a strategy consisting of two consecutive RMCEs: in RMCE 1 
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potential targetable sites were pre-screened at the clone-pool level; in RMCE 2, cells with 
targetable sites were recovered from the pool. Since the integration sites were thoroughly 
pre-screened, a smaller number of single clones were needed to derive a master cell line. By 
using a traceable fluorescent marker, the screening of integration sites with high and stable 
expression levels was accomplished at the same time. The process may be further supported 
by the addition, for instance of S/MARs. S/MAR elements alleviate position effects from 
variable integration sites and, in addition, they protect the FRTs within the same chromatin 
boundaries. Although the correlation between active transcription sites and 
RMCE-competence remains uncertain, it appears plausible that a high accessibility will 
provide both, high expression levels and Flp-mediated recombination rates.  
The true bottleneck of RMCE is the unfavorable (since bi-molecular) mode of the 
recombinase-catalyzed reaction. Although the rate of RMCE can be improved by 
recombinase activity and the concentration of exchange partners, the cells with net 
replacement of exchange cassette will usually remain a minor portion among the transfected 
cells. Therefore the most crucial step is the rational isolation of RMCE-events, which will be 
discussed in the following. 
3.2. How to efficiently isolate RMCE-competent loci with 
high expression level 
3.2.1. How to isolate integration sites with stable and high 
expression level  
Since a major aim of this study is the establishment of cell lines for protein production, stable 
and high expression levels of these lines are the predominant criteria. The GOI is targeted to 
a pre-characterized locus, the properties of which will determine the expression level of the 
GOI. In Strategy 1, cells with a high expression level of d2eGFP were selected after the first 
round of RMCE (Fig 2.3C and D). But the high expressers collected after this step did not 
consistently include the highly-expressed original targets. In the refined Strategy II, the 
expression level was directly evaluated after micorporation by the integrated fluorescent 
marker d2eGFP, which is a part of the parental vector. In this process potential 
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RMCE-competent clones were collected, by double sorting, only from the population, which 
had already proven an exceptional expression level. Expression of these selected cells could 
be analyzed in the absence of selection pressure, approaching the natural condition for a 
gene in its genomic environment. After two rounds of RMCE, clones bearing a consistently 
exchangeable site were further tested for their long-term stability in absence or (as a control) 
the presence of selection pressure. Only clones maintaining stable expression levels over 3-4 
months were chosen to establish master cell lines for production purposes. Although all 
candidate clones harbor a single copy of the same reporter gene, they still show variable 
expression levels indicating the extent to which expression properties depend on the genomic 
environment. For example, for non-S/MAR-flanked clones (Fig 2.17B), “C1-1”, “C1-17” and 
“C1-20” had a stable expression level of d2eGFP, while “C1-12” underwent a decline. The 
situation was similar even for S/MAR-flanked clones (Fig 2.18B), e.g. clone “C2-2”, “C2-9” and 
“C2-23” were stable while “C2-21” was unstable. Even within the control series, the 
co-expression of a selection marker did not guarantee the stability of expression level for all 
different loci.  
Fig 2.19 and Fig 2.20, shows that, nevertheless, there are some clones that are stably 
expressed in the absence of selection pressure. Only these stable expressers were 
candidates to yield master cell lines for further applications.   
3.2.2. How to efficiently isolate RMCE-competent loci 
3.2.2.1. The difficulties to isolate RMCE-competent loci 
Usually, the identification of master clones with a unique exchangeable site relies on intensive 
screening of a huge variety of clones. To enable an efficient RMCE process, random 
integration(s) of the target should be stringently avoided since otherwise any extra integrated 
copy might constitute a secondary target and cause chromosomal recombination of 
homologous sequences. Therefore, an elaborate selection strategy was needed to select 
clones harboring a unique target site with dominant target-ability over random integration.  
Selection strategies used for the RMCE-based engineering of embryonic stem (ES) cells 
provide useful examples. Seibler et al. (1998) applied RMCE in the framework of the classical 
―tag and exchange‖ strategy, in which a hygtk positive/negative (+/-) selection marker flanked 
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by F and F3 sites was used to randomly tag different integration sites. Successful 
Flp-mediated replacement of hygtk cassette in a clonal cell was then enriched by Ganc 
counter-selection to exclude non-exchanged cells. Targeting frequencies at different 
integration sites varied between 21% and 38%, which was still adequate. Later on a number 
of alternatives served to improve the efficiency by adding positive selection. As an example, 
an ATG-deficient neomycin gene was positioned downstream from the parental cassette. 
RMCE-mediated integration provided the missing translational start codon such that 
Neomycin could be expressed (Seibler 1999). A major disadvantage of this strategy is that the 
neomycin gene is left behind in the targeted host genome, which is the situation causing 
epigenetic silencing of the GOI (Artelt et al. 1991). In principle, this effect can be overcome if 
the selection marker is f´loxed  ´ (flanked by identical LoxP sites) enabling its removal by a 
pulse of Cre-recombinase once targeted integration events have been selected in G418. 
Roebroek et al. (2006) reported that targeting efficiencies of ~100% could be reached if 
positive and negative selection were used in conjunction and 63% if only positive selection 
was applied.  
The application of RMCE for the development of production cell lines is just beginning. A 
HEK-293 derived cell line, Flp293A, has been described that integrates different retroviral 
vectors via RMCE using the ATG-supplementation RMCE-strategy mentioned above 
(Schucht et al. 2006). Unfortunately, the efficiency by which the specific cell line could be 
identified was not addressed as was its targeting efficiency. More recently, a CHO cell line 
producing erythropoietin was established by RMCE-mediated integration of the erythropoietin 
(EPO) expression cassette into a previously characterized locus with the appropriate 
characteristics (Kim and Lee 2008). Obviously, however, the targeting efficiency of the 
pre-selected loci was extremely low. Only one single completely exchanged clone was 
isolated using a co-expressed, independent positive selection marker.  
In order to identify targetable loci, we started our study using the ―negative selection strategy‖, 
which had been successfully applied in ES cells. In Strategy I (Fig 2.3A), the parental cassette 
containing a hygtk positive/negative selection marker was electroporated into CHO wt cells to 
obtain a high proportion of cells with single copy integration (Baer et al. 2000). In order to 
enrich the cells undergoing successful RMCE, Ganc counter-selection was performed to 
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exclude any non-exchanged parental cells. Originally unexpected, among the Ganc resistant 
cells the majority was non-fluorescent (>90% for non-S/MAR-flanked cells, >70% for S/MAR- 
flanked cells, Fig 2.3C), indicating that a silenced tk gene in the parental cells had caused 
Ganc resistance for the non-fluorescent population. After the high expressers had been 
enriched by FACS, authentic exchange events could be verified by PCR (Fig 2.3E), which 
supports the value of negative selection. However, using specific primer pairs silenced tk 
genes and randomly integrated exchange cassettes were also detected in the fluorescent cell 
population (Fig 2.4 and Fig 2.5). Such a random integration phenomenon has never been 
observed for ES cells. This can be ascribed to the fact that diploid cells (but not transformed 
cell lines) recruit circular constructs only by RMCE and not by random integration events.  
As a consequence, one more selection step became necessary before clonal screening could 
be started, to pre-select cells that owe their fluorescence only to RMCE. To this end a second 
RMCE was added to restore the starting situation by replacing the fluorescent marker with the 
hygtk gene (Fig. 2.6). Only cells that received d2egfp via RMCE lost fluorescence and 
integrated a hygtk gene at the same locus (loci) again. These independent exchange events 
could be enriched by FACS counter-sorting. The randomly integrated hygtk gene(s) would 
lead to the survival of any other type of non-targeted cells, characterized by the continuous 
expression of d2eGFP. Fig 2.6B demonstrates that, for non-S/MAR-flanked cells, there was 
no notable exchange even for cells pre-screened after RMCE 1. But For S/MAR-flanked cells, 
a significant non-fluorescent population arose, as expected. This interpretation was validated 
by negative controls, performed in the absence of Flp. We can therefore safely conclude that 
the Flp activity induced an authentic RMCE event.  
Subsequently, clonal cells were screened and characterized. PCR analyses (Fig 2.6C) 
showed that the majority (34 out of 59 isolated clones) had an authentic exchange of the 
single copy at the target site (Fig 2.7C and D). The efficiency of the second round of RMCE 
therefore was >56%, which substantially reduces the efforts of clonal screening and 
characterization. Since, for single clones, no random integration(s) of exchange cassette were 
detected, positive selection is sufficient to enforce and enrich targeted integration. This was 
confirmed by RMCE on the characterized single “clone 57” (Fig 2.8). Hyg-resistant “clone 57” 
was selected with G418 and shown to have undergone exchange for the neo-d2egfp cassette. 
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The death of the cells co-transfected without Flp expressing vector indicated very rare random 
integration of exchange cassette(s) in the targeted fluorescent cells.  
Nevertheless, a number of non-anticipated properties or even drawbacks have to be 
mentioned:  
1. The clonal diversity among the S/MAR-flanked clones is low. According to the similar 
hybridization pattern on Southern blot analyses, the seven clones shown in Fig 2.7C and 
Fig 2.7D could be related or even identical. The reason for such a phenomenon may lie in 
the dominant exchangeability of some loci which profit from the presence of S/MAR 
elements as chromatin borders. Alternatively, S/MARs have a targeting potential directing 
the associated transgenes to certain class of loci, e.g. regions of the genome with 
S/MAR-like sequences. 
2. An extra copy of intact but silenced parental cassette was detected in all the screened 
single clones (Fig 2.7). This copy must have been integrated at the establishment phase 
of parental cells and silencing events might have been enriched by the counter-selection 
with Ganc in RMCE 1. Such a copy should be inactive both for expression and 
recombination. In theory, it should not influence the exchange of a GOI, but the unknown 
epigenetic background may have caused unexpected and uncontrollable alterations 
during the further development of this cell line. Therefore a clean exchange at a unique 
targetable site remains one prerequisite. Although Strategy I successfully improved the 
efficiency of isolating targetable sites, it still lacks the selection of clones with a unique 
targetable site. Besides that, the negative selection strategy with Ganc enriched for many 
spontaneous silencing events, which should be avoided.   
3. For non-SMAR-flanked cells, there is no consistent exchangeability for the pre-screened 
clones after RMCE 1. Probably too few diverse cells were pre-screened due to the fact 
that less than 1% expressed d2eGFP at all. The second possibility is that the unknown 
epigenetic alterations may have mutated the F and/or F3 sites. Since no clonal cells could 
be screened, sequencing of these sites was not applicable. The addition of S/MAR 
elements on the other hand not only protected the expression of the targeted gene from 
silencing, it may also have served to protect the FRT sites (Cobellis et al. 2005).  
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Because our ultimate goal was an RMCE system not needing drug selection, “clone 57”, 
which had been fully characterized after two rounds of RMCEs, was chosen for establishing a 
master cell line for further RMCE cycles. As described above, “clone 57” harbors a unique 
targetable site in addition to a silenced, recombination-inactive F/F3 site. After RMCE with a 
d2egfp gene and double sorting, authentic exchange events were detected by PCR analysis. 
But events of this type only represented a minimum of the whole population, which was 
concluded from similar expression patterns of cells transfected with or without Flp 
recombinase. Although it is feasible to have RMCE in the absence of drug selection, an even 
more stringent selection is needed to recover cells with only targeted integration from the 
mixture. 
To summarize: consisting of two consecutive RMCEs, Strategy I could serve to efficiently 
isolate master clones with a high expression level and a consistent exchangeability. 
Nevertheless, the following points did remain for further refinement: 
1- only clones with high expression level sites should be subjected to the selection of 
exchangeable sites;  
2- the selection process should enrich clones with a unique targetable site;  
3- the selection strategy should reduce random integration events of the exchange cassette, 
especially in case RMCE is performed in the absence of a selection pressure.  
3.2.2.2. Refinements in Strategy II 
 As discussed in chapter 2.3.1, high expressers were pre-selected by sorting for 
d2eGFP expression to ensure only active transcriptional sites to be tested for their 
exchangeability. The broad expression pattern of the sorted cells indicates variable 
integration sites (Fig 2.11D). The clones were not tested for expression stability 
because low expressers would overgrow the high expressers with time, especially in 
the absence of selection pressure. Fig 2.11E demonstrates that, after the cells were 
cultured for more than 2 months, a population of non-expressers emerged. Since 
d2eGFP expression was restored by RCME 2, the expression stability can be tested 
by FACS for single clones after screening with or without selection pressure. Only 
correctly targeted clones with high and homogenous expression were chosen for 
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master cell lines. The second advantage of this optimization is that master cell lines 
are marked by fluorescence. Cells for which a GOI has been introduced by RMCE can 
be easily collected and sorted by FACS due to the loss of fluorescent expression, 
which provides a fast and convenient way to enrich targeted clones other than by a 
drug selection.  
 In Strategy II, parental cells were fluorescently marked. After exchange for the hygtk 
gene,  targeted cells were enriched by sorting the non-fluorescent population (Fig 
2.12D). In RMCE 1, the parental cells with either one or multiple integration sites lost 
fluorescence by replacing all d2egfp cassette(s). Cells with a partial replacement of 
d2egfp could, in principle, establish Hyg-resistance but they would still be fluorescent. 
This situation was verified by the proof of authentic exchange events in the fluorescent 
population via PCR (Fig 2.13). Some single clones were recovered from the 
non-fluorescent population after RMCE 1. In each of 24 authentically exchanged 
single clones, only 1 clone was detected with two integration sites in case of 
non-S/MAR-flanked cells (data not shown). For S/MAR-flanked cells, all clones 
contained a unique integration site (data not shown). Obviously, RMCE 1 not only 
pre-selects the potential targeted cells but also does enrich the cells with a unique 
targetable integration site.   
 For Strategy II, a ―promoter trap‖ principle was used to reduce interferences from 
randomly integrated cassette(s). In the absence of positive selection, random 
integration is favored over RMCE-mediated integration since RMCE can only take 
place at a single site whereas random integration can be widespread in the whole 
genome. Although authentic exchange events could be detected for Strategy I by PCR 
(“clone 57”) in the absence of positive selection, the exchanged cells cannot be easily 
distinguished from the mixture due to the high percentage of random integrations (Fig 
2.9). But after the promoter was positioned outside of the parental cassette, the 
expression of a promoter-less targeted cassette can only be initiated by 
RMCE-mediated integration. This was demonstrated by selecting the targeted cells 
with a drug expressing gene (either hygromycin or neomycin): in Fig 2.12C and Fig 
2.14C, only the targeted cells could survive the corresponding drug selection. In the 
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absence of selection pressure, 3 different master clones were exchanged for a GOI. 4 
or 5 single clones derived from each master line were characterized for random 
integration of the GOI. Only a single case was found for which an extra random 
integration had taken place (Fig 2.23C). Therefore, the ―promoter trap‖ strategy 
successfully trapped cells with only a targeted integration both in presence and 
absence of a selection pressure. There were very rare events leading to random 
integration(s) next to an endogenous promoter but in these cases expression was very 
weak. The fact that the ―promoter trap‖ strategy does not permit the exchange of the 
pre-existent promoter for a different one is only an apparent one: since the expression 
of a transgene depends on a particular set of interactions between the promoter and 
its genomic environment, its exchangeability does not mean a realistic advantage. It 
has been shown by Seibler (Dissertation, 1999) that even the inversion of a 
transcription unit at a given locus can significantly alter the expression properties. 
Therefore this property does not limit the applications of Strategy II.  
Considering the various optimization steps in Strategy II, a new method could be developed to 
efficiently isolate targetable clones with both a unique integration site and a high expression 
level. After two consecutive RMCEs, 21 of 24 screened clones showed the desired 
target-ability in the non-S/MAR approach; 10 of 24 screened clones showed an equivalent 
target-ability in the case of S/MAR flanks (Table 2.1). Some of these were tested for their 
expression stability in long term culture. Only the clones that showed stable and homogenous 
expression were chosen as a source of master cell lines.  
The timeline was as follows:  
- It took 10 days to pre-select the high expressers.  
- The selection of targeted cells in two RMCEs required 10-15 days.  
- The final step to screen clonal cells could be performed in another 20 days.  
Therefore, it took approximately 2 months to identify targetable clones with a unique 
integration site and a high expression level. Compared to the traditional ―integration and 
selection‖ strategy (6 months; Wurm 2004) or the conventional ―tag-and-targeting‖ RMCE 
strategy (4 months; Schucht et al. 2006), our strategy is definite time-efficient (Fig 3.2). 
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Figure 3.2: Timeline comparison between different cell line development strategies 
In traditional process, it takes minimum of 12 months to transfer the GOI and selection marker 
gene into the host, to screen high expresser and to develop large-scale production processes 
(Wurm 2004). In the tag-and-targeting strategy, isolation of master clones relies on the 
screening of numerous targetable single clones with high expression properties, which is still 
laborious and time-consuming (4 months). In our refined strategy, we speed up the isolation of 
master clones by two consecutive RMCEs. The efficiency is significantly improved to reduce 
the number of clones needed to be screened. For both of two latter strategies, development of 
production cell lines for various GOIs takes one month and the optimization of down-stream 
processing only needs to be done once. 
The apparent low clone diversity in S/MAR-flanked clones observed for Strategy I (Fig 2.16) 
also appeared in Strategy II indicating that this phenomenon is not a coincidence. This low 
diversity was not introduced during the establishment of parental clones following 
microporation, since the broad and heterogeneous expression profile of the S/MAR-flanked 
cells was similar to non-S/MAR-flanked cells (Fig 2.11D). Therefore diversity must have been 
lost in the RMCE steps, which means that some locus has absolute exchange preference 
over others. The underlying is unknown. Its explanation and exploitation will need more 
genomic information about the particular characteristics of these sites.  
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3.2.3. The development of production cell lines from master cell 
lines 
In this study, the non-S/MAR-flanked master line “C1-23”, and S/MAR-flanked master lines 
“C2-1” and “C2-14” were chosen for the development of production cell lines. The GOI was 
constructed as part of a bicistronic vector containing GOI-IRES-pac, which provided the 
option to select the targeted cells with Puromycin. Since the potential targeted cells appeared 
right after co-transfection of the exchange vector and Flp expressing vector (Fig 2.22B), the 
positive RMCE-events were FACS-isolated from the mixture immediately in order to reduce 
the overgrowth by non-targeted cells. 9 or 11 single clones were detected with GOI 
expression from 100 screened clones that were derived from each of master line. The 
remainder showed extremely low or non-detectable expression, probably due to the 
background of transfected but non-exchanged master cells. Characterization of several GOI 
expressing clones proved a clean RMCE-mediated integration of GOI for most cases. Only in 
one case the single copy of a randomly integrated GOI was traced. Therefore the targeting 
efficiency of three master cell lines varies between 8.8% and 11% in the absence of drug 
selection (Table 2.2). If selection with Puromycin was also performed, a significantly larger 
population of non-fluorescent cells was observed in case the cells were co-transfected with 
exchange vector and Flp expressing vector (data not shown). This underlines the efficiency of 
positive selection for enriching targeted cells. Due to time restrictions clonal cells were not 
screened in this case.  
At the time being, this is the first report describing the recovery of pure RMCE-mediated 
integration events in the absence of any drug selection. The average targeting efficiency for 
different integration sites is about 10%, which is reasonable for an efficient selection process. 
If really required, the efficiency can be much increased by a drug selection due to the high 
efficiency appeared in the two rounds of consecutive RMCEs. Previous studies with a positive 
selection strategy (Neo) showed much lower stringency and efficiency to select high 
producers, and it required more time for cell line development. In the strategy described here 
about 1 month is required to derive a suitable production cell line from a master cell line. This 
includes the screening characterization procedures for higher producers. Since various GOIs 
can be targeted to the same genomic locus, the downstream processes and regulatory 
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approval can be simplified. 
For yet unknown reasons the productivity of the isolated producers has so far remained 
behind expectations and there are indications that the production of this particular GOI in 
CHO cells is limited by an unknown mechanism. Since three different master lines with 
different integration sites were used to create production cell lines, the productivity among the 
GOI producers derived from different master lines would be expected to differ. This is 
obviously not true since all of the fully characterized clones with correct targeted integration 
agreed in their expression level (around 40 ng/ml, Fig 2.23A). Therefore there must exist 
steps apart from the transcription rate that govern the productivity of this GOI, e.g. the 
translation machinery, the endoplasmic reticulum machinery responsible for folding, 
post-translational modification, and secretion. If the productivity still remains below 
expectation, one would have to quantify both the intracellular and secreted portions of the 
GOI. Therefore, additional selection principles may become necessary covering the 
post-transcriptional steps, most notably the secretion capacity. If transcriptional silencing of 
the particular GOI is a matter, the use of DNA elements with chromatin opening function and 
anti-repressor elements could be considered (Benton et al. 2002; Kwaks et al. 2005). 
3.3. How to improve and stabilize recombinant gene 
expression level 
Recombinant gene expression in mammalian cells is a multistep process in which 
transcription is followed by posttranscriptional processing, translation and posttranslational 
modification. Subsequent steps involve protein folding under the control of chaperones. 
After a transgene is stably integrated into a host genome, at a molecular level, the transgene 
is wrapped by histones to form nucleosomes, which are the basic building block of chromatin. 
The density of chromatin structure surrounding the integration site determines the 
accessibility of different transcriptional regulatory elements, which explains that the efficient 
expression of the transgene is highly dependent on the site of integration. Therefore 
enhancing gene transcription can be achieved by improving integration sites. One of the 
approaches towards this end is the introduction of artificial domain borders, i.e. S/MAR flanks 
which are able to prevent the surrounding heterochromatin from influencing the transcription 
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of the transgene.  
During the past decade, much has become known about the role of chromatin modification on 
epigenetic gene regulation. The DNA methylation in the promoter sequence and modifications 
according to the histone code determine whether a gene is active or not. Since an open and 
active chromatin domain is generally associated with histone acetylation, histone deacetylase 
inhibitors (HDACi) can be used to augment the transcriptional potential as shown in this study, 
especially if applied in the context of S/MARs, which render the transgene amenable to the 
histone machinery (Bode et al. 1986; Klehr et al. 1992).  
Both of these two approaches were applied to improve and stabilize the expression level of a 
targeted gene, which will be discussed in the following contest respectively.   
3.3.1. The function of S/MARs 
3.3.1.1. The function of S/MARs on gene expression 
Scaffold/matrix attachment regions (S/MARs) are experimentally identified sequences 
associated with the protein/RNA backbone of the nucleus. Many reports have been published 
on the application of S/MARs to augment expression levels in different cell lines (Zahn-Zabal 
et al. 2001; Abranches et al. 2005; Goetze et al. 2005; Girod et al. 2005). Besides their role in 
structuring chromatin domains, S/MARs are involved in chromatin remodeling and 
subsequent transcriptional activation events (Bode et al. 2000a). S/MARs also act as 
―insulators‖ to block the spread of DNA methylation, which pose repressive effects on 
transgene expression (Bode et al. 2000a). When the expression cassette was linked to 
S/MARs, multi-copy tandem integrations could be observed (Klehr et al. 1991; Bode et al. 
1996). In such cases, the expression level could be further increased due to arrays of several 
transgenes. These kinds of S/MAR functions are reflected by several observations in this 
study: 
1. In Strategy I, after first round of RMCE, the S/MAR-flanked cells surviving from 
Ganc-selection showed higher expression of d2eGFP than the non-S/MAR-flanked cells 
(Fig 2.3C). Obviously S/MARs suppress chromosomal position effects, imparting 
position-independent expression. S/MARs directing multi-copy integration of d2egfp is the 
second possible reason for the higher expression. Finally, being recombinogenic elements 
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S/MARs have the potential to increase the rate of RMCE due to their strand-separation 
potential, which leads to more RMCE-positive cells within the mixture (Fig. 2.3C).  
2. In strategy II, after the d2egfp cassette was integrated into the CHO cell genome, the 
highest expressers were enriched twice by FACS. At the stable stage, the S/MAR-flanked 
cells only showed a slightly stronger expression than non-S/MAR-flanked cells (Fig 2.11D). 
But after the cells were cultured for extended times, especially in the absence of selection 
pressure, S/MAR-flanked cells showed a more stable expression, i.e. fewer cells were 
silenced than for non-SMAR-flanked cells. As anticipated, S/MARs have the function to 
protect and maintain transgene expression by alleviating the negative effects from 
chromatin modifications. 
3. In Strategy II, after two rounds of RMCE, the expression of individual clones was 
evaluated by FACS analyses (Fig 2.18 and Fig 2.19). Obviously, there are more 
S/MAR-flanked high expressers than non-S/MAR-flanked ones (for instance, 
S/MAR-flanked clones “C4, C6, C8, C9, C11, C15, C19, C21”). Southern blot analyses 
proved that some of the clones contained multi-copy integrations (Fig 2.16D), which may 
be one reason for their higher expression. Repeat-induced silencing phenomena were 
also found in some of these cases (Fig 2.18), e.g. “C2-21” showed a decline of expression 
over long term culture (Garrick et al. 1998). Multi-copy integration phenomenon was rarely 
found in the non-S/MAR-flanked clones.  
3.3.1.2. The function of S/MARs on RMCE rates  
In this study the support function of S/MAR elements on the rate of RMCE became obvious. 
On one hand, acting as simple spacers S/MARs protect the FRT sites during the integration 
process from exonuclease degradation. For instance, in Strategy I, after RMCE 1, the 
pre-selected non-S/MAR flanked cells could not be further exchanged (Fig 2.3D), which is 
likely due to deletion or mutation of FRTs. On the other hand, S/MARs are recombinogenic 
sequences with an increased propensity to undergo strand separation (Bode et al. 2006). This 
property supports the crossover reactions between FRT sites, to increase the rate of RMCE. 
Therefore, in Strategy I, there were more S/MAR-flanked d2eGFP expressing cells than 
non-SMAR-flanked cells after the first round of RMCE (Fig 2.3C). This phenomenon was not 
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observed for Strategy II because of additional measures such as the ―promoter trap‖ principle 
and exactly comparable sorting processes.  
3.3.2. The function of HDACis   
Compounds to create and maintain a favorable chromatin conformation are in wide use for 
bioprocess development (De Leon Gatti et al. 2007; Backliwal et al. 2008). Since an open and 
active chromatin domain is generally associated with histone acetylation, histone deacetylase 
inhibitors (HDACi) such as sodium butyrate (NaBu), valproic acid (VPA) are used to boost 
transcription by maintaining histone acetylation (Hunt et al. 2002; Backliwal et al. 2008). 
S/MAR-mediated transcriptional effects can be augmented by the addition of histone 
deacetylase inhibitors (such as NaBu), which in this context cause  high levels of 
core-histone acetylation (Schlake et al. 1994). This is the case since S/MARs constructs  
approach the machinery involved in histone turnover (Hendzel et al. 1994). In a model study 
NaBu raised transcriptional levels < 2 for S/MAR-free constructs while its effect was ~4 for 
the same test gene with one flanking S/MAR or ~30 if elements ―E‖ and ―W‖ constituted the 
domain borders (cf. Fig. 1 in Schlake et al. 1994). In the present study, NaBu or VPA was 
added to the culture medium of single clones that were screened and characterized for a 
single copy integration, both for non-S/MAR- and S/MAR-flanked clones. An increase factor of 
5~6 was found in most of non-S/MAR-flanked clones after a 48-hours treatment with NaBu 
(Fig 2.21A). In contrast, S/MAR-flanked clones showed an increase of more than 10 fold (Fig 
2.21B). Some non-S/MAR-flanked clones e.g. “C1-3” and “C1-22” also boosted transcription 
similar to clones with authentic S/MAR-flanks. Since only integration sites with high 
expression level were selected, the notable (though somewhat smaller) response for 
non-SMAR-flanked cassettes indicates that our pre-selected cells have incorporated the 
expression unit next to S/MAR-like elements pre-existing at the site of integration. NaBu was 
also added to selected single clones with a high productivity of the targeted GOI. An increase 
comparable to the corresponding master lines was observed (data not shown). VPA is a C5 
short fatty acid like NaBu. Since the inhibition of histone deacetylase is not as strong as NaBu 
(Davie 2003), the function of VPA on transcription remains below that of NaBu (Fig 2.21).     
Since HDACi arrests the cell cycle in G1 (and to some extent in G2), the available energy will 
be used for proteins other than those involved in replication. Both factors together explain the 
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beneficial action of these approaches.  
3.4. Perspectives 
3.4.1. Analyses of cis-regulatory elements on transgene 
expression 
In this study, S/MAR elements showed the propensity to improve RMCE rate but this 
conclusion needs more evidence. For instance, S/MAR elements could be used to flank the 
exchange cassette as well. RMCE rate can be evaluated by the exchange between both 
S/MAR-flanked parental cassette and exchange cassette (Fig 3.3). The option to select 
targetable sites will then open the possibility to explore unknown functions of cis-acting 
elements in an identical genomic setting (Goetze et al. 2005). 
 
Figure 3.3 Strategy to analyze the function of cis-regulatory elements on transgene 
expression and/or targeting efficiency 
At a unique targetable site in host genome, variable cis-regulatory elements posed upstream 
and/or downstream of a reporter gene can be targeted into the exactly same integration site. 
Therefore the comparison of different cis-regulatory elements on transgene expression or 
RMCE rate can be performed within same genomic environment. 
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3.4.2. Multiplex RMCE 
The synthesis and characterization of more FRT mutants that show cross recombination with 
themselves but not FRTwt enable the multiplex RMCE principle (Turan, Diplom Thesis, 2007). 
The well characterized master clones in this study provide a host for the introduction of a 
second target site. The efficient screening strategy established here could quickly identify a 
new target site by integration of a second fluorescent marker (e.g. RFP; Fig 3.4). The 
expression ratio of two sites can be evaluated by the fluorescent intensity on FACS analysis. 
This provides the possibility, for instance, to optimize the expression level of H- and L- 
antibody chains. Last but not least the multi-target capacity could enable sophisticated mouse 
models for the analysis of not a single but multiple gene functions.  
 
Figure 3.4: Principle of Multiplex RMCE 
A second target site flanked by another pair of FRT sites can be identified as described in 
Strategy II. The light chain (LH) and heavy chain (HC) for an antibody can be simultaneously 
integrated into the target sites, which can be characterized by the loss of fluorescence. The 
ration of LC and HC can be optimized by the ratio of green and red intensity before targeting.  
Material and Methods 
79 
4. Material and Methods 
4.1. Material 
Chemicals used in this study were obtained from Amersham, Bayer, Biolabs, Biorad, Gibco, 
Merck, Roche and Sigma. Enzymes were purchased from Biolabs and Roche. 
Oligonucleotides were synthesized by MWG. Radioactive chemicals were purchased from 
Amersham-Buchler. 
DNA was sequenced by the ―Genome Analysis‖ (GNA-) group at the Helmholtz Centre for 
Infection Research (Braunschweig, Germany). 
Plastic materials used in cell culture was bought from Gibco, Greiner, Nunc, Sarstedt and 
Seromed. 
4.2. Computer programs 
Analysis of DNA sequences, search for sequences, restriction sites for endonucleases and 
cloning simulation were done with Vector NTI 6.0 (Invitrogen). The analysis of 
Phosphorimager data was performed with the program ImageQuaNT from Molecular 
Dynamics. The processing of FACS analyses data was done with the program Cell Quest Pro 
and FACSDiva (Becton Dickinson). Processing and PC conversion of images was performed 
via Adobe Photoshop. This manuscript was written with the programs Word and Excel from 
Microsoft. Chromas Version 1.45 (Conor McCarthy, School of Health Science, Griffith 
University Queensland, Australia) was used for analyzing sequencing results. 
4.3. Instrumentation 
Centrifuges Minifuge Heraeus-Christ  
Biofuge pico 
Eppendorf Centrifuge 5417 C 
Hettich Rontanta/S 
Thermo-centrifuges (Rotors) Sorvall RC 5 (SS34 and GSA) 
Minifuge Heraeus-Christ 
Biofuge fresco 
Photometer Nanodrop Spetrophotometer ND-100, Peqlab 
Scintillation Counter Beckman Counter LS 6500 
Electrophoresis Chamber BRL Horizon 58 
BRL Horizon 1114 
BRL Horizon 2025 
Microscope Olympus CK2 
Leitz Labovert 
Phosphor-Imager  Molecular Dynamics Storm 860 
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Exposition Chamber Molecular Dynamics Exposition Cassette for the 
phosphor-imager 
FACS FACSCalibur from Becton Dickinson 
FACSAria from Becton Dickinson 
Cell Culture Incubator Labotect CO2-inkubator C2000 from 
Labor-Technik-Goettingen 
Clean Benches Mecaplex, Sterilcard Hood VBM600 and SG400 
Heraeus, HLB 2448 
Heraeus, HSP 18 
Thermo-Cycler Biometra T3 Thermocycler 
Vortexer Scientific Industries Vortex Genie2 
Electroporator Biorad Gene Pulser and Pulse Controller 
Microporator MicroPorator MP-100 from NanoEnTek Inc. 
Hybridization Incubator Stuart Scientific Hybridization Oven 
Milli-Q Water Purifier Millipore Milli-Q 
Power Supply Bio-RAD Power PAC 300 
Cell Counter  Schaerfe System CASY1 
4.4. Medium and buffer solutions 
All reagents were dissolved in ―Millipore‖ water and sterile filtrated (pore size of 2 µm). 
Penicillin/Streptomycin solution (100x) 1.212 g Penicillin/200 ml (10000 U/ml), 
2 g Streptomycin/200 ml (10 mg/ml), 
adjust to pH 7.0 with NaOH, stored at -20°C 
Glutamine solution (100x) 29.23 g Glutamine dissolved to 1 l solution, 
stored at -20 °C 
PBS 140 mM NaCl, 27 mM KCl, 7.2 mM Na2HPO4, 
14.7 mM KH2PO4 (pH 6.8 - 7.0), stored at 4°C 
TEP 500 ml sterile PBS, 
0.6 ml 0.5 M EDTA (final conc.: 6 mM), 
15-20 ml Trypsin (0.1 - 0.2%; depending on the 
activity) 
Puromycin 5 mg/ml in H2O, stored at -4°C 
G418 100 mg/ml in H2O, stored at -20°C 
Hygromycin 650 U/ml in H2O, stored at -4°C 
Ampicillin 50mg/ml in ethanol, stored at -20°C  
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TE 10mM Tris/HCl, pH 8.0, 1 mM EDTA, pH 8.0 
Medium for CHO-K1 cell Dulbecco’s Modified Eagle’s Medium 
(DMEM)/Nut.Mix F12 (HAM) medium (1:1), 
with 10% fetal calf serum (FCS), 20 mM 
glutamine, 60 µg of penicillin/ml and 100 µg of 
streptomycin/ml 
LB medium 10 g/l Bacto-Trypton, 5 g/l Bacto-yeast extract, 
10 g/l NaCl, autoclavated 
4.5. Molecular cloning technologies 
4.5.1. Polymerase Chain Reaction (PCR) 
PCR is used to amplify a defined DNA fragment with specific primers that recognize 
appropriate sequences in the leading and lagging strand of DNA. PCR will allow to amplify 
DNA stretch about a million-fold so that its size and nucleotide sequence can be determined. 
There are three major steps in PCR, which are repeated for 30~35 cycles: 
1. Denaturation 
During the denaturation (the DNA double strand melts yielding single strands) all 
enzymatic reactions are stopped (for example, the extension from the previous step). 
2. Annealing 
In this step primers anneal to the template DNA and the polymerase can combine with the 
template DNA to start copying a DNA strand. 
3. Elongation 
The optimum elongation temperature is 68°C for the Expand Long Template Enzyme mix 
(containing thermostable Taq DNA polymerase and Tgo DNA polymerase, a thermostable 
DNA polymerase with proofreading activity) from Roche. The bases (complementary to 
the template) are coupled to the primer on the 3’ side (the polymerase adds dNTPs from 5’ 
to 3’, reading the template from 3’ to 5’; bases are added complementary to the template). 
Reaction components for a standard PCR reaction: 
10xPolymerase buffer  
dNTPs mixture (25 mM for each nucleotide) 
Primer mixture (10 pmol/µl) 
Expand Long Template Enzyme mix from Roche (5 unit/µl) 
DNA template (100 pg plasmid DNA or 100 ng HWM DNA) 
The reaction is adjusted with water to 25 µl volume. 
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A PCR program example: 
Predenaturation  95°C 3 mins 
Denaturation 95°C 15 Secs 
Annealing  60°C 1 min 
Elongation 68°C 2 mins (depending on the length 
of amplification, 1 min/1 kb) 
Cycling  go to denaturation step 34 cycles 
Ending 4°C  
4.5.2. Enzymatic restriction of DNA 
Standard DNA manipulations were carried out essentially according to Sambrook (Sambrook 
et al. 1989). In each restriction reaction, an amount of 0.5~1 µg DNA dissolved in 10 µl H2O 
was digested with 0.5~2 units restriction enzyme over 1~2 hrs at the optimal reaction 
temperature for the enzyme. The reaction buffers (10x) were provided together with the 
restriction enzyme by the producing company. When required, BSA was added to the 
restriction reaction at a concentration of 100 µl/ml. The resulting DNA fragments were 
analyzed on an agarose gel. 
4.5.3. Dephosphorylation of DNA-fragments 
Alkaline Phosphatase (AP) from Roche 
To avoid self-ligation of a DNA fragment digested with one restriction enzyme, the fragment 
was dephosphorylated with alkaline phosphatase. The restricted and purified fragment was 
mixed with 1 µl of alkaline phosphatase and 1 µl buffer and adjusted to 20 µl with H2O. 
Dephosphorylation was done at 37°C for 30 mins. After that, 1 more µl alkaline phosphatase 
was pipetted in and incubated for another 30 mins. 
4.5.4. Fill in reaction of DNA-fragment with sticky ends 
1 µg of DNA with sticky ends was treated with 1 U Klenow enzyme (NEB) in the presence of 3 
µl dNTP-mix (25 mM for each nucleotide) and 5 µl Buf II (NEB) in a total volume of 50 µl. The 
mixture was incubated for 15 mins at 25°C and terminated by heat inactivation (20 mins at 
75°C). 
4.5.5. Gel electrophoresis 
The size of a DNA-fragment or entire plasmid was determined by analysis on 1-2% agarose 
gel. The required amount of agarose was dissolved in 1xTAE buffer, melted and poured into 
an electrophoresis chamber together with ethidium bromide solution (1g/ml). A volume of 10% 
v/v loading buffer was added to DNA samples at a ratio of 1/6. Samples were loaded onto the 
gel by using 1xTAE as running buffer. The electrophoresis was performed at 20-100 Volt/cm 
for about 30 mins. The agarose gel was photographed under UV light with wavelength at 260 
nm. 
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4.5.6. DNA extraction from agarose gels 
QIAquick Gel Extraction Kit (QIAGEN) 
After separation on agarose gel, a DNA-fragment of interest was cut out from the gel with a 
lancet, weighted and treated by the means of the QIAquick Gel Extraction Kit (QIAGEN). The 
gel slice was weighted and put in an Eppendorf tube. 3 volumes of Buffer QX were added to 1 
volume of gel (100 mg~100 µl). One volume of 100% isopropanol was added if the fragment 
was larger than 4 kb or smaller than 500 bp. The mixture was incubated at 50°C for 10 mins to 
dissolve the gel. To bind DNA, the completely dissolved DNA was pipetted onto the QIAquick 
Spin Column from the 2 ml collection tube and centrifuged for 1 min. 750 µl PE buffer was 
loaded onto the column. The mixture was incubated 5 mins at room temperature. After 1 min 
centrifugation, the column was put into a clean 1.5 ml Eppendorf tube. 25 µl H2O was added 
to the center of the column directly to elute the DNA by 1 min centrifugation, 13,000 rpm. 
4.5.7. Ligation 
In each ligation reaction, an amount of 1 µl of template DNA and 3 µl of insertion fragment 
were mixed with 1 µl T4 DNA ligase (NEB). 10x ligase buffer was used and the whole solution 
was adjusted to 10 µl with H2O. The reaction was run 2 hrs or overnight at room temperature. 
The ligation mixture was spread onto an agar plate supplemented with corresponding 
antibiotic, which was in turn put into 37°C room overnight. 
4.5.8. Plasmid preparation 
Mini preparation 
STET:     8% Sucrose, 0.5% Triton 50 mM EDTA, 10 mM Tris (pH 8) 
1. Pick up colonies from an agar plate and dissolve in 2 ml LB medium supplemented with 
corresponding antibiotic, e.g. 50 μg/ml ampicillin, shake at 180 rpm in 37°C room for 6 hrs; 
meanwhile, steak the related colony onto an agar plate with the same marker as the 
medium; place the plate in 37°C room overnight. 
2. Take 2 ml medium to 2.0 ml eppendorf tube, centrifuge for 30 secs, 13,000 rpm. 
3. Decant supernatant. Add 500 µl STET to re-suspend the pellet by vortexing. 
4. Add 50 µl 10 mg lysozyme/1 ml TE solution (stored at -20°C) and mix by inverting the tube 
10~15 times. Stand the tubes at room temperature for 2~3 mins. 
5. The Eppendorf tubes are heated on a heat-block at 95°C for 90 secs, then centrifuged for 
5 mins a 13,000 rpm. 
6. The pellet is removed with toothpicks. Add 50 µl 8M NH4Ac and 500 µl isopropanol. Mix by 
inverting the tubes. Then centrifuge for 5 mins, 13,000 rpm. 
7. Decant the supernatant and wash the precipitation with 500 µl 70% v/v ethanol. 
8. Centrifuge for 5 mins at 13,000 rpm and decant the supernatant. The tubes were dried by 
standing at room temperature for 10~15 mins. 
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9. Elute the precipitation in 20~30 µl H2O. 
The mini prepared plasmid DNA was used to verify the correct cloning sites by enzymatic 
restriction.  
Maxi preparation 
Pick up corresponding positive colony into 250 ml LB medium and shake overnight at 180 rpm 
in 37°C room. Collect the medium and use QIAGEN Plasmid Maxi Kit to harvest the plasmid 
DNA.  
1. Harvest the bacterial cells by centrifugation for 10 mins, 7,000 rpm with GSA rotor at 4°C. 
2. Re-suspend the bacterial pellet in 10 ml Buffer P1. 
3. Add 10 ml Buffer P2, mix gently but thoroughly by inverting 4-6 times, and incubate at 
room temperature for 5 mins. 
4. Add 10 ml pre-chilled Buffer P3, mix immediately but gently by inverting 4-6 times, and 
incubate on ice for 20 mins. 
5. Centrifuge for 30 mins at 4°C, 13,000 rpm with GSA rotor. 
6. Equilibrate a QIAGEN-tip 500 by applying 10 ml Buffer QBT, and allow the column to 
empty by gravity flow. 
7. Filter the supernatant with pre-wetted folded filter paper through QIAGEN-tip 500. 
8. Wash the QIAGEN-tip 500 with 30 ml Buffer QC twice. 
9. Elute DNA with 15 ml Buffer QF. 
10. Precipitate DNA by adding 10.5 ml room-temperature isopopanol to the eluted DNA. Mix 
and centrifuge immediately for 30 mins at 4°C, 13,000 rpm with a karbon rotor. 
11. Wash DNA pellet with 5 ml of room-temperature 70% ethanol, and centrifuge for 10 mins 
at 4°C, 13,000 rpm with a karbon rotor. Carefully decant the supernatant without 
disturbing the pellet. 
12. Air-dry the pellet for 5-10 mins, and re-dissolve the DNA in a suitable volume of TE buffer. 
4.6. Use of Escherichia coli (E.coli) 
4.6.1. E.coli strains 
DH10B: mcrA, mcrB, mrr, hsdR17, deoR, recA1, endA1, lacZDM15 (Gibco BRL) 
4.6.2. Preparation of agar plates 
To the LB-medium 15 g agar was added per liter. For preparation of agar plates containing 
Ampicillin, a sterile Ampicillin stock solution (50 mg/ml in ethanol) was diluted 1/1000 into the 
medium. 
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4.6.3. Preparation of electro-competent bacteria 
5 ml overnight culture was added to 1 l LB medium. The cells were grown at 37°C under 
strong shaking until the cell suspension reached an OD600 of 0.5 - 1 and subsequently they 
were centrifuged for 10 mins in a cooled GS3-rotor at 3,000 rpm. The cell pellet was 
re-suspended in 1 l cold water and centrifuged as mentioned before. After this centrifugation 
step the pellet was re-suspended in 500 ml cold water and was centrifuged again as 
mentioned above. Then the cell pellet was re-suspended in 20 ml cold 10% glycerin (v/v), 
centrifuged and then re-suspended in 2-3 ml 10% glycerin. This cell suspension was divided 
into aliquots (50µl), shock frozen into liquid nitrogen and stored at -70°C. 
4.6.4. Transformation of DNA into E.coli by electroporation 
The electroporation-competent bacteria DH10B were thawed on ice. 2-3 µl ligation DNA was 
mixed with 50 µl of bacteria gently. The mixture was moved to pre-chilled electroporation 0.2 
cm cuvette quickly, tapping the top of the cuvette until the mixture settled evenly to the bottom. 
The sample was pulsed once using 2.5 kV, 25 µF and 200 Ω. The time constant should range 
between 4 to 5 ms. Immediately after transformation, 1 ml LB medium was added to suspend 
the cells. The cells were incubated at 37°C, 180 rpm for 1 hr. After that, the mixture was 
spread on an agar petri plate and incubated over night at 37°C. 
4.6.5. Conservation of bacterial colonies 
For short term conservation bacteria were plated on agar plates, incubated at 37°C overnight 
and kept at 4°C. 
For long-term conservation a 1 ml overnight culture was mixed with 87% glycerin in a 1/1 ratio 
and conserved at -70°C. 
4.7. DNA analysis 
4.7.1. Extract genomic DNA (high molecular weight DNA, HMW) 
Modified Bradleys 10 mM Tris/HCl, pH 7.5, 2 mM EDTA, 10 mM 
NaCl, 0.5% SDS, autoclavated 
Confluent cells on 6-well plate were washed with 2 ml PBS. 500 µl modified Bradleys buffer. 1 
mg/ml proteinase K was added on the cells and mixed gently. The viscous mixture was 
transferred to 1.5 ml Eppendorf tube and stored in 55°C incubator over night. The Eppendorf 
tube was spun down. 1 ml 75 mM NaAc in 100% ethanol (stored at -20°C) was added. After 
vortexing, the tube was incubated at room temperature for 2~3 hr, then centrifuged for 5 mins, 
5,000 rpm. Supernatant was decanted. The pellet was washed with 0.5 ml 70% ethanol 
(stored at -20°C) and incubated at room temperature for 30 mins, twice. After 5 mins, 5,000 
rpm centrifugation, the pellet was dried at room temperature for 10 mins. 20-30 µl TE was 
added to the pellet and incubated at 37°C for 30 mins. Finally, the DNA solution was sheared 
by pipetting and stored at 4°C.   
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4.7.2. Southern Blot analysis 
Blotting 
10 µg HMW DNA was digested overnight with an appropriate enzyme and run on 0.8% 
agarose gel in 1xTAE buffer. DNA was transferred to a positively charged Nylon membrane 
(Amersham) in 0.4 M NaOH. On a gel carrier plate 2 Whatman papers soaked in 0.4 M NaOH 
were placed, then a Whatman paper bridge was formed between two sides of buffer reservoir. 
On top of the bridge the gel was placed upside down and the nylon membrane, soaked in 
water was put onto the gel while eliminating air bubbles between the gel and the membrane. 
On top of the membrane 3 wet papers were positioned. A 10 cm stack of dry tissue paper was 
added to absorb the buffer. The blot apparatus was covered with plastic foil and a 3 kg weight 
was put on top. It took overnight for the transfer of DNA to the membrane. The nylon 
membrane was then neutralized 5 times in 2xSSC for 5 mins, backed at 80°C for 2 hrs before 
it was ready to use in the hybridization experiment. Hybridizations were done in buffer 
containing 0.5 M NaxHyPO4 (1M Na2HPO4 and 1M NaH2PO4 were mixed in a ratio of 4/1), pH 
7.2, 7% SDS and 2 mM EDTA. The membrane had to be pre-hybridized for at least 30 mins in 
65°C incubator. 
Labeling 
Random priming with the ―Redi-Prime DNA labeling system‖ (Amersham) 
Labeling mix:   dATP, dGTP, dTTP, exonuclease free Klenow enzyme, oligonucleotide 
primer (9-mer)  
For the labeling reaction, a commercially available system from Amersham was used. The 
reaction mix was available as a freeze-dried pellet in an Eppendorf tube. First 2.5-100 ng DNA 
probe in 45 µl TE buffer was denatured in boiling water for 5 mins and put on ice immediately. 
The DNA and 5 µl of α[32P]dCTP were added to the labeling tube and mixed by pipetting. The 
mixture was incubated for 10 to 30 mins at 37°C. 2 µl of 0.5 mM EDTA was pipetted to the 
mixture to stop the reaction. 
Hybridization 
After labeling, the sample was separated from unincorporated nucleotides over a Sephadex 
G50 column. For this purpose, the ready to use stacked Micro-SpinTM G50 column from 
Pharmacia Biotech was used. Perfected packing of the column was reached by spinning the 
columns for 1 min at 3,000 rpm. The labeling mix was put on the column drop by drop and 
centrifuged through the column for 2 mins at 3,000 rpm. The labeled probe was denatured in 
boiling water bath for 2~5 mins, then put on ice immediately and added to the pre-hybridized 
membrane. Hybridization proceeded overnight in 65°C incubator.    
Washing 
After hybridization the membrane was washed with the following steps: 
1. 250 ml 2xSSC/0.5% SDS   5 mins   RT 
2. 500 ml 2xSSC/0.5% SDS   30 mins   65°C 
3. 250 ml 2xSSC/0.5% SDS   5 mins   65°C 
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Washing steps were performed until the signal on blot was lower than 40 ips with hand 
counter measurement. 
Exposition 
After washing, cover the blot with Whatman 3MM paper to remove most of excess moisture. 
Wrap moist blot in plastic film prior to and put into Molecular Dynamics Exposition Cassette 
for the phosphor-imager overnight. After that, the screen was scanned (Molecular Dynamics). 
Re-hybridization 
For re-hybridization, the signal was eliminated by washing several times in boiled 0.1% 
SSC/0.5% SDS. To check if the signal was completely removed, the stripped blot was 
exposed again, until there was no image on it. Re-hybridization was performed as described 
previously. 
4.8. Fluorescence-activated Cell Sorting (FACS) 
4.8.1. Scanning by FACSCalibur (Becton Dickinson) 
EPICS 2% inactivated FCS (heat FCS in 56°C water bath for 30 mins) in PBS 
The confluent cells on 6-well plate were washed with 2 ml PBS and collected by trypsinization 
with 500 µl TEP. The suspension was mixed with 500 µl PBS and centrifuged for 5 mins, 
1,000 rpm at 4°C. The supernatant was removed. The pellet was re-suspended in 400 µl 
EPICS with 10 µg/ml propidium iodide (PI) to stain the dead cells. Fluorescence (GFP) 
expression was measured on FACSCalibur (Becton Dickinson). The excitation wavelength for 
GFP was 488 nm and emission was detected at 488 nm (on Fl-1). The PI emission at 620 nm 
was detected on Fl-3. Dead cells were excluded via an FSC-H vs. Fl-3 dot plot. The GFP 
expression was evaluated in an FSC-H vs. Fl-1 dot plot on the live cells. 1E5 events were 
collected. Data were acquired and analyzed by CellQuestTM Pro. 
4.8.2. Sorting by FACSAria (Becton Dickinson) 
The confluent cells on a 6-well plate were collected as described above. The suspended cells 
were passed through a 40 µm gauze to exclude cell clumps. Single cells or cell populations 
expressing GFP were separated by FACSAria (Becton Dickinson). GFP expressing cells can 
be detected and sorted at wavelength of 488 nm on Fl1-A. PI emission was detected at 
wavelength of 620 nm on Fl3-A. Doublets were excluded via an FSC-H vs. FSC-A dot plot. 
The dead cells were excluded via an FSC-A vs. Fl3-A dot plot. The sorting gate was the 
combination of the live cell gate, the doublet discrimination gate and the dot plot gate on 
FSC-A vs.Fl1-A. The sorted cells were incubated several days in the medium with 5 µg/ml 
Gentamycin. Data were acquired and analyzed by FACSDiva software. 
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4.9. Cell culture 
4.9.1. Cell lines 
CHO-K1: Chinese Hamster Ovary (ECACC Nr. 85051005) 
4.9.2. Cell culture 
4.9.2.1. Cell incubation 
CHO-K1 cells were incubated at 37°C with 5% CO2 in incubator. 
4.9.2.2. Cell passage 
When the cells have grown confluent on the container (dishes, plates or flasks), they were 
washed with PBS once. TEP was added to the cell container for trypsinization. After several 
minutes, cells were suspended by pipetting and a portion of 1/20-1/10 was transferred to fresh 
medium. The amount depended on the passage time and the size of cell container. Change 
medium every three days until the cells grow confluent for the next passage. 
4.9.2.3. Freezing and Thawing cell 
Freezing 
Grow cells on a little flask until confluence (about 5x106 cells). Wash cells with 5 ml PBS once 
and trypsinize them with 1 ml TEP. Suspend cells with 4 ml medium and then centrifuge for 5 
mins, 1,000 rpm. After that, remove supernatant and re-suspend the cell pellet in 5 ml FCS 
with 5% DMSO. Aliquot the cells to 3 or 4 freezing vials (Bio-Freeze-Vials, Costar) and put 
them on ice immediately. After one hour on ice, package the vials with paper towels and 
freeze them into -70°C refrigerator. After 12 hrs, the freezing tubes can be moved to liquid 
nitrogen.  
Thawing 
Take the frozen vial out of liquid nitrogen and thaw it in 37°C water bath. Add 4 ml medium 
and centrifuge for 5 mins, 1,000 rpm. Remove supernatant in order to get rid of DMSO. The 
cell pellet was re-suspended in 5 ml medium and filled in a little flask.   
4.9.3. Gene transfer methods 
4.9.3.1. Electroporation 
1E6 logarithmically growing, semi-confluent cells were washed with 5 ml PBS once and 
collected in 500 µl TEP. The pellet was re-suspended in 0.7 ml pre-chilled DMEM/HAM 
medium together with 3µg linearized DNA. The cell-DNA mixture was placed in 0.4 cm cuvette 
and pulsed at 360 V, 800 µF capacity and infinite resistance with a Biorad Gene Pulser and 
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Pulse Controller. The electroporated cells were plated onto a 10-cm plate containing 10 ml 
DMEM/HAM medium. 
4.9.3.2. Microporation 
5E5 logarithmically growing semi-confluent cells were collected by trypsinization and 
re-suspended in 100 µl Buffer R with 5 µg linearized DNA. The cell-DNA mixture was 
aspirated using Microporator 100 µl pipette and microporated at 1620 V with MicroPorator 
MP-100. The pulse width was 10 ms and the sample was pulsed three times. The 
microporated cells were seeded onto a 10-cm plate containing 10 ml DMEM/HAM medium. 
4.9.3.3. Transfection for RMCE 
One day prior to transfection, the cells were seeded in 6-well plate (1.2E5 cells/well). 4 hrs 
before transfection fresh medium was put on cells. Metafectene (Biontex) and DNA solution 
should have an ambient temperature and should be gently vortexed prior to use. Mix 3 µg of 
exchange DNA and 1µg of Flp expression DNA in 100 µl serum free medium. Incubate the 
mixture at room temperature for no longer than 5 mins. Mix 30 µl metafectene and 100 µl 
serum free medium. Combine the DNA solution and metafectene solution together and then 
incubate in room temperature for 15-20 mins. Add the mixture to one well drop by drop. One 
day post-transfection, the cells were treated with 2.5 µg/ml Puromycin for 48 hrs. For transient 
transfection, the cells were harvested 48 hrs after transfection. For stable transfection, PBS 
rinsed cells were passaged into the medium supplemented with corresponding antibiotic. 
Medium exchange was performed every 3 days. The selection was finished generally after 2 
weeks. 
4.9.3.4. Transfection for RMCE-negative control 
Mimicking RMCE transfection, the neutral vector BSpac-Δp (de la Luna et al. 1988) only 
encoding Puromycin was used in place of the Flp expression for the control transfection: If 
integration happened, it was independent on Flp-recombinase. 
4.10. Measurement of GOI expression 
The measurement of GOI expression was accomplished by InVivo Biotech Services GmbH 
(Berlin). Due to commercial reasons, the details of the measurement cannot be revealed. 
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5. Plasmids and Oligonucleotides 
5.1. Plasmids 
5.1.1. Existing Plasmids used in this study 
pF3-hygtk-F The hygromycin thymidine kinase fusion gene (hygtk) under control of the 
HSV-thymidine kinase promoter is flanked by FRT3 and FRTwt sites 
(Schlake and Bode 1994). 
pF3ESGTNWF The sv40 promoter driven GTN fusion gene (Green fluorescent protein, 
Thymidine kinase and Neomycin resistant gene) is linked to S/MAR-E 
(upstream) and S/MAR-W (downstream) elements; the whole cassette is 
flanked by FRT3 and FRTwt sites (Baer 2002).  
pd2egfp-basic   The d2egfp gene (a destabilized variant of enhanced green fluorescent 
protein gene with a half-life of approximately two hrs; Clontech, CA, 
USA). 
peGFPN1-mcs   The enhanced green fluorescent protein gene under control of the 
cytomegalovirus promoter (Clontech, CA, USA). 
pF3-pgkhygtk-F     The hygromycin thymidine kinase fusion gene (hygtk) under control of the 
phosphoglycerate kinase (pgk) promoter is flanked by FRT3 and FRTwt 
sites (Fiering, S.; Seattle). 
pGFP-C1    The neomycin resistant gene (Clontech, CA, USA). 
pF3SGTNF The sv40 promoter driven GTN fusion gene is flanked by FRT3 and FRTwt 
sites (Baer 2002). 
pCR4TOPO-GOI The synthetic GOI is cloned into TOPO vector (InVivo Biotech Services, 
Berlin). 
pmcsF3bpAFmcs The bovine polyA signal (bpA) flanked by FRT3 and FRTwt sites sits 
between a multi-cloning site (Baer 2002). 
pFlpe The enhanced Flp is under control of the CAGGS-promoter (Stewart, F.; 
EMBL). 
pFlpo-Puro Flpo is lined to the puromycin resistant gene via an IRES elements; the 
bicistronic construct is driven by the CAGGS-promoter (Turan, S.; HZI). 
pBSpac-Δp The puromycin resistant gene lacks the prokaryotic promoter (de la Luna 
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et al. 1988). 
5.1.2. Plasmids constructed in this study  
pESGTNW 
The ~7.0 kb fragment including SMAR-E, GTN and SMAR-W elements was amplified with 
primer pair P2369 and P2423 on pF3ESGTNWF as a template. The ~2.0 kb fragment 
containing amp gene and Ori element was amplified with primer pair P2427 and P2428 on the 
same template. Both of fragments were digested with BamHI and DraIII and then ligated.  
pEF3-hygtk-FW 
The F3-hygtk-F cassette was amplified with primer pair P2433 and P2439 on pF3-hygtk-F as 
a template. The ~2.8 kb SalI/SpeI digested PCR fragment was inserted into SalI/SpeI 
restricted pESGTNW, in which the GTN fusion gene was replaced by the F3-hygtk-F cassette. 
pcmvd2egfp-basic 
The cmv promoter was amplified with primer pair P2472 and P2484 on template 
peGFPN1-mcs. The ~650 bp MluI/XhoI digested PCR fragment was inserted into MluI/XhoI 
digested pd2egfp-basic, in which the expression of d2eGFP was driven by the cmv promoter.  
pF3-cmvd2egfp-F 
The cmvd2egfp fragment was amplified with primer pair P2472 and P2496 on template 
pcmvd2egfp-basic. The ~1.7 kb KpnI/SpeI restricted PCR fragment was inserted into 
KpnI/SpeI digested pF3MCSF, in which the cmvd2egfp fragment was flanked by FRT3 and 
FRTwt sites. 
pF3-cmvneod2egfp-F 
The neo gene was amplified with primer pair P2536 and P2539 on template pGFP-C1. The 
~800 bp NheI/BspEI restricted PCR fragment was inserted into NheI/BspEI restricted 
pF3-cmvd2egfp-F, in which the neod2egfp fusion gene was driven by the cmv promoter.  
pF3-d2egfp-F 
The ~1.1 kb EcoRI/BamHI digested d2egfp gene from pd2egfp-basic was inserted into ~2.4 
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kb EcoRI/BamHI restricted pF3MCSF, in which the d2egfp gene was flanked by FRT3 and 
FRTwt sites. 
pcmvF3-d2egfp-F 
The F3-d2egfp-F cassette was amplified with primer pair P3077 and P3993 on pF3-d2egfp-F 
as a template. The ~1.2 kb NheI/SalI digested PCR fragment was inserted into ~3.4 kb 
NheI/SalI digested pcmvd2egfp-basic, in which the F3-d2egfp-F cassette was under control of 
the cmv promoter. 
pEcmvF3-d2egfp-FW 
The cmvF3-d2egfp-F fragment was amplified with primer pair P2084 and P2439 on 
pcmvF3-d2egfp-F as a template. The ~1.9 kb SalI/SpeI digested PCR fragment was inserted 
into SalI/SpeI restricted pEF3-hygtk-FW, in which the F3-hygtk-F was replaced by the 
cmvF3-d2egfp-F cassette. 
pF3-hygtk-F(w/p) 
pF3-hygtk-F was digested with MluI and XhoI and filled with Klenow. The blunt 5.3 kb 
fragment was self-ligated, in which the tk promoter was deleted (w/p). 
pF3-GTN-F(w/p) 
pF3SGTNF was digested with SalI and PpuMI and filled with Klenow. The blunt 5.2 kb 
fragment was self-ligated, in which the sv40 promoter was deleted (w/p). 
pF3-GOI-F 
The ~480 bp SpeI/NotI fragment digested from pCR4TOPO-GOI was inserted into ~2.5 kb 
SpeI/NotI digested pF3MCSF, in which the GOI was integrated between FRT3 and FRTwt 
sites. 
pF3-cmvGOI-F 
The ~620 bp EcoRⅤ/NheI digested GOI from pF3-GOI-F was inserted into ~3.0 kb 
EcoRV/NheI digested pF3-cmvneod2egfp-F, in which the GOI replaced the neod2egfp fusion 
gene. 
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pF3-cmvGOI bpA-F 
The cmvGOI fragment was amplified with primer pair P2084 and P3076 on pF3-cmvGOI-F as 
a template. The 1.1 kb SalI/SacI digested PCR fragment was inserted into SalI/SacI digested 
mcsF3bpAFmcs, in which a bovine polyA signal was insert into downstream of the cmvGOI 
fragment. 
pF3-GOIbpA-F 
pF3-cmvGOI bpA-F was digested with NheI and SalI and filled with Klenow. The blunt 3.0 kb 
fragment was self-ligated, in which the cmv promoter was deleted. 
pF3-GOI-IRES-pac-F 
The IRES-pac fragment was amplified with primer pair P3802 and P3803 on pFlpo-Puro as a 
template. The ~2.0 kb NotI digested PCR fragment was inserted into NotI digested and 
dephosphorated pF3-GOIbpA-F, in which a GOI-IRES-pac bicistronic construct was formed. 
5.2. Oligonucleotides  
p2369 5’-GCA GGA GTC GGA TCC TGA ATT CTA AGC CAG TAG TAC CTG C-3’ 
p2423 5’-GAC GCT GCC CAC TTG GTG AAT TCA GCA AGG TCG CCA CGC ACA AGA 
T-3’ 
p2427 5’-GAC GCT GCC GGA TCC GGC CCT GCA TTA ATG AAT CGG CCA ACG 
CGC-3’ 
p2428 5’-GCA GGA GTC CAC CAA GTG GGC GCG CCC GAT CGC CGC GGT TA-3’ 
p2433 5’-GAC GTC GCC GTC GAC TTA CGA ATT CAT CGA TAA GCT TGA AGT TCC 
TAT ACT ATT T-3’ 
p2439 5’-GCA GGA GTC ACT AGT GCC AGG GGC TAC CAT GGA GAA GTT CCT ATT 
CCG AAG TTC-3’ 
p2472 5’-GAC GTC GCC ACG CGT GGT ACC CCG TAT TAC CGC CAT GCA T-3’ 
p2484 5’-CTC GAG ATC TGA GTC CGG TAG CGC TAG CGG ATC TGA CGG TT-3’ 
p2496 5’-GCA GGA GGC GCG CCA CTA GTC CTC CCA CAC CTC CCC CTG AAC CTG 
AA-3’ 
p2536 5’-GCC GAC ACC GCT AGC ATG ATT GAA CAA GAT GGA TT-3’ 
p2539 5’-GAC GCC ACC T CC GGA GGG GGG GGG GGA AGA ACT CGT CAA GAA 
GGC GAT AGA-3’ 
p3077 5’-GAC GCT GCT AGC AAG CTT GAA GTT CCT ATA CTA TTT GAA GAA TAG 
G-3’ 
p3993 5’-GAC GTC GTC GAC GCA GGG CCG CGA AGT TCC TAT TCC GAA GT-3’ 
p2084 5’-GAC GCT GCC GCT AGC GTC GAC GTT AGT TAT TAA TAG TAA TCA ATT 
ACG GG-3’ 
p3076 5’-GAC GTC GAG CTC GAG CGG CCG CGA ATT CGC CCT TAA GCT TAG-3’ 
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p3802 5’-GAC GAC GCG GCC GCT ATA TGT TAT TTT CCA CCA TAT TGC-3’ 
p3803 5’-GTG GAC GCG GCC GCT AAT GCA GCG GAT CCA GAC ATG ATA-3’ 
p2494 5’-CAA TTA ATG TGA GTT AGC TC-3’ 
p2471 5’-GTC GCG GTG AGT TCA GGC TT-3’ 
p1230 5’- 
p2484 5’-CTC GAG ATC TGA GTC CGG TAG CGC TAG CGG ATC TGA CGG TT-3’ 
pGFP6 5’- ACACGCTGAACTTGTGGCCGTTCACGTCGC-3’ 
p1452 5’- GAGTAGCATTAACACGGCAAAGTCATTTTC-3’ 
p2495 5’- TCATTTTCTAGTTCCGGTAT-3’ 
p2822 5’- GAGGAGTAGAAGGTGGCGCGAAGGGGCCAC-3’ 
p2834 5’- GATATCGGTACCGTCGACTTACGAATTCAT-3’ 
p2546 5’- CGATCGGTGCGGGCCTCTTCGCTATTAGGCCAGC-3’ 
p1515 5’- GAGGAACCCAAGGAGACATGAG-3’ 
p1513 5’- GAGAACCTGCGTGCAATCCATC-3’ 
p3073 5’-GGG AGA ACT TTT GGA AGC CC-3’ 
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6. Abbreviations 
α    alpha 
amp    ampicillin resistence gene 
ATCC    American Type Culture Collection 
β    beta 
bp     base pairs 
cf.    confer 
CHO    Chinese hamster ovary cell line 
cHS4   DNase I hypersensitive Site 4 at the 5’ end of chicken β-globin locus 
cmv    cytomegalovirus promotor 
Cre    causes recombination (Cre-Recombinase) 
d2eGFP destabilized variant of enhanced green fluorescent protein with a half-life of 
approximately two hours 
d2egfp destabilized variant of enhanced green fluorescent protein gene  
DHFR dihydrofolate reductase 
dNTP    desoxyribonucleotidtriphosphate  
DMSO    dimethylsulfoxid 
DNA    desoxyribonucleic acid 
E. coli    Escherichia coli 
EDTA    ethylenediaminetetraacetic acid 
e.g.    for example 
eGFP    enhanced green fluorescent protein 
egfp   enhanced green fluorescent protein gene 
ES    Embryonic Stem cell 
F    wild type FRT site 
Fn     mutant FRT Site 
FACS    fluorescence-activated cell sorter or sorting 
FCS    fetal calf serum  
Flp    Flippase recombinase 
Flpe    enhanced Flp 
Flpo   of mouse codon-optimized Flp-variant  
FRT    Flp-recognition target  
g     gramme 
G418    aminoglycoside-2’-deoxystreptine (Gentamycin-derivative) 
Ganc    ganciclovir 
GFP    green fluorescent protein 
GOI   gene of interest 
GS    glutamine synthetase 
GTN   egfp, thymidine kinase and neomycin resistant fusion gene 
HDAC   histone acetyl transferase 
HDACi   HDAC inhibitor(s) 
hr     hour 
hrs    hours 
HMW-DNA   high molecular weight DNA 
HDACi   histone deacetylase inhibitors  
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hygtk   hygromycin and thymidine kinase fusion gene 
kb     1,000 bases    
kbp    1,000 base pairs 
kV     1,000 volts 
l     liter 
λ    lambda 
LCR   locus control region 
LD     limited dilution  
loxP  locus of crossing over of P1 (target sequence for the Cre recombinase) 
µg     microgramme 
µl     microliter 
µM    micromolar 
M     molar 
MAR    matrix attachment region 
mg    milligramme 
min    minute 
mins   minutes 
ml     milliliter 
mM    millimolar 
MSX    methionine sulfoximine 
MTX    methotrexate 
nm    10-9 meter 
neo    neomycin-phosphotransferase gene 
NLS   nuclear localization signal  
ori     origin of replication 
p     plasmid 
P    primer 
pFAR   plasmid Free of Antibiotic Resistance 
PBS    phosphate-buffered saline 
PCR    polymerase chain reaction 
PEV    position effect variegation 
RMCE    recombinase-mediated cassette exchange 
SAR    scaffold attachment region 
SDS    sodiumdodecylsulfate 
S/MAR    scaffold/matrix attachment region 
sec     second 
secs   seconds 
NaBu   sodium butyrate  
SSR   site-specific recombination 
sv40    Simian Virus 40 
tk     thymidine kinase 
TSA   trichostatin A  
U     units 
UCOE   ubiquitous chromatin opening elements  
V     volt 
VPA   valproic acid  
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v/v     volume/volumen (volumen procent) 
wt     wild type 
Xis    excisionase 
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